[go: up one dir, main page]

TW201339131A - Herbicidally active sulfinimidoyl-and sulfonimidoylbenzoyl derivatives - Google Patents

Herbicidally active sulfinimidoyl-and sulfonimidoylbenzoyl derivatives Download PDF

Info

Publication number
TW201339131A
TW201339131A TW102105508A TW102105508A TW201339131A TW 201339131 A TW201339131 A TW 201339131A TW 102105508 A TW102105508 A TW 102105508A TW 102105508 A TW102105508 A TW 102105508A TW 201339131 A TW201339131 A TW 201339131A
Authority
TW
Taiwan
Prior art keywords
alkyl
halo
cycloalkyl
group
phenyl
Prior art date
Application number
TW102105508A
Other languages
Chinese (zh)
Inventor
哈姆特 雅倫斯
西蒙 多納萊頻
史提芬 勒爾
漢斯卓 戴屈
艾莫 蓋茲威勒
克里斯多福 羅辛哲
德克 屈穆勒
Original Assignee
拜耳智慧財產有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 拜耳智慧財產有限公司 filed Critical 拜耳智慧財產有限公司
Publication of TW201339131A publication Critical patent/TW201339131A/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Sulfinimidoyl-and sulfonimidoylbenzoyl derivatives of the formula (I) are described as herbicides. In this formula (I), R, R', X, W and Z are radicals such as hydrogen, organic radicals such as alkyl, and other radicals such as halogen. Q is a cyclohexanedionyl, pyrazolyl or isoxazolyl radical.

Description

具除草活性之亞磺醯亞胺基-及磺醯亞胺基苯甲醯基衍生物 Herbicidal sulfinimide- and sulfonimidobenzamide derivatives

本發明係有關除草劑之技術領域,特定言之係有關選擇性控制有用作物中之闊葉及雜草之除草劑。 The present invention relates to the technical field of herbicides, in particular to herbicides for the selective control of broadleaf and weeds in useful crops.

WO 03/014071 A1及WO 2011/012247 A1揭示具有除草活性之苯甲醯基環己二酮類,其在苯基環之3-位置上帶有烷基亞氧硫基、烷基亞磺醯基或烷基磺醯基。於苯基環之3-位置上帶有烷基亞氧硫基、烷基亞磺醯基或烷基磺醯基之除草活性苯甲醯基吡唑係自WO 2008/125214 A1及WO 2009/149806 A2中已知。US 2011/0144345 A1及WO 2004/052849 A1分別揭示苯基環之3-位置上帶有磺醯亞胺基之苯甲醯基衍生物。然而,此等文獻中所提及化合物之除草活性及/或作物相容性總是不足。 WO 03/014071 A1 and WO 2011/012247 A1 disclose herbicidal benzepidine cyclohexanediones having an alkyl oxysulfoxide group, an alkyl sulfinium ring at the 3-position of the phenyl ring. Or alkylsulfonyl. Herbicidal benzionylpyrazole having an alkyl oxysulfoxide, alkylsulfinyl or alkylsulfonyl group at the 3-position of the phenyl ring is from WO 2008/125214 A1 and WO 2009/ Known in 149806 A2. US 2011/0144345 A1 and WO 2004/052849 A1 each disclose a benzamidine derivative having a sulfonium imine group at the 3-position of the phenyl ring. However, the herbicidal activity and/or crop compatibility of the compounds mentioned in these documents are always insufficient.

本發明之一目的在於提供比先前技藝已知之化合物具有改良性質之除草活性化合物。 It is an object of the present invention to provide herbicidal active compounds having improved properties over compounds known in the prior art.

已發現在苯基環之3-位置上帶有亞磺醯-或磺醯-亞胺基之苯甲醯基衍生物適用為除草劑。 It has been found that a benzamidine derivative having a sulfinium- or sulfonium-imino group at the 3-position of the phenyl ring is suitable as a herbicide.

因此,本發明提供一種式(I)亞磺醯亞胺基-及磺醯亞胺基苯甲醯基衍生物或其鹽 其中代號及指數之定義如下:Q為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基、R6S、R7(R8)N,Rb、Rc、Rf及Rg分別獨立為氫或(C1-C4)-烷基,Rd、Re 分別獨立為氫或(C1-C4)-烷基或與其所附接之碳原子共同形成羰基,Rh 為氫、(C1-C6)-烷基磺醯基、(C1-C4)-烷氧基-(C1-C6)-烷基磺醯基、苯基磺醯基、硫苯基-2-磺醯基、苯甲醯基、苯甲醯基-(C1-C6)-烷基、苯甲基,其中最後述及之5個基團可視需要經鹵素、(C1-C4)-烷基或(C1-C4)-烷氧基單取代或多取代,Ri 為(C1-C4)-烷基,Rk 為氫、(C1-C4)-烷基、(C3-C7)-環烷基,A及Y 分別獨立為氧、S(O)n、N(R3)、羰基或(C1-C4)-伸烷基,其係經n個R9基團取代並插入n個選自下列各物所組成群中之 元素:氧、S(O)n、N(R3)及羰基,X 為硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烯基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、(C3-C6)-環烯基-(C1-C6)-烷基、鹵-(C3-C6)-環烯基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、(R1)2N(R1)N(O)C、R1(O)C(R1)N(O)C、R2O(O)C(R1)N(O)C、(R1)2N(O)C(R1)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、(R1)2N(R1)N(O)C-(C1-C6)-烷基、R1(O)C(R1)N(O)C-(C1-C6)-烷基、R2O(O)C(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)C-(C1-C6)-烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、 R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基、其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,Z 為氫、硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烯基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、(C3-C6)-環烯基-(C1-C6)-烷基、鹵-(C3-C6)-環烯基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、(R1)2N(R1)N(O)C、R1(O)C(R1)N(O)C、R2O(O)C(R1)N(O)C、(R1)2N(O)C(R1)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1O(O)2S、 (R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、(R1)2N(R1)N(O)C-(C1-C6)-烷基、R1(O)C(R1)N(O)C-(C1-C6)-烷基、R2O(O)C(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)C-(C1-C6)-烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基, W 為氫、鹵素、硝基、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C7)-環烷基、鹵-(C3-C7)-環烷基、(C1-C6)-烷氧基、鹵-(C1-C6)-烷氧基、(C1-C6)-烷基-(O)nS-、(C1-C6)-鹵烷基-(O)nS-、(C1-C6)-烷氧基-(C1-C4)-烷基、(C1-C6)-烷氧基-(C1-C4)-鹵烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N、R1(O)C(R1)N或R2(O)2S(R1)N,R 為(C1-C6)-烷基、(C2-C6)-烯基或(C2-C6)-炔基,其分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1S(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1O(R1)N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1C(O)S、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S及(R5O)2(O)P,或為(C3-C6)-環烷基、(C3-C6)-環烯基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R1)-(C1-C6)-烷基、雜芳基-N(R1)-(C1-C6)-烷基、雜環基-N(R1)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基或雜環基-S(O)n-(C1-C6)-烷基,其各環狀部份基團經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)- 烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1S(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1O(R1)N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1C(O)S、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R’ 為氫、硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-烯基、鹵-(C3-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R2O(O)C、(R1)2N(O)C、R2S(O)C、(R1)2N(S)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、(R1)2N、R2(O)nS、(R2)3Si-(C1-C6)-烷基-(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、R2(O)2S(R1)N(O)2S、(R5O)2(O)P、(R2)3Si、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、 m2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、(R2)3Si-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個苯基、雜芳基及雜環基之環狀部份基團經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R1 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R3)-(C1-C6)-烷基、雜芳基-N(R3)-(C1-C6)-烷基、雜環基-N(R3)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基、雜環基-S(O)n-(C1-C6)-烷基,其中最後述及之15個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)- 烷基、(C3-C6)-環烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS、R3O(O)2S、(R3)2N(O)2S及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R2 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R3)-(C1-C6)-烷基、雜芳基-N(R3)-(C1-C6)-烷基、雜環基-N(R3)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基、雜環基-S(O)n-(C1-C6)-烷基,其中最後述及之15個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS、R3O(O)2S、(R3)2N(O)2S及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R3 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基或苯基,R4 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基或苯基,R5 為氫或(C1-C4)-烷基,R6 為(C1-C4)-烷基或為苯基,其係經m個選自下列各物所組成群中之基團取代:鹵素、硝基、氰基、(C1-C4)-烷基、(C1-C4)- 鹵烷基、(C1-C4)-烷氧基及(C1-C4)-鹵烷氧基,R7 為氫、(C1-C4)-烷基或(C1-C4)-烷氧基,R8 為氫或(C1-C4)-烷基,或R7及R8 與其所附接之氮原子共同形成5-或6-員飽和、部分飽和或不飽和環,其再包含n個選自氮、氧及硫所組成群中之雜原子,並經m個選自下列各物所組成群中之基團取代:鹵素、氰基、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基及(C1-C4)-鹵烷氧基,R9 為鹵素、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基、(C1-C4)-鹵烷氧基或(C1-C4)-烷氧基-(C1-C4)-烷基,m為0、1、2、3、4或5,n為0、1或2,s為0、1、2或3,t為0或1。 Accordingly, the present invention provides a sulfinimido- and sulfonimidobenzamide derivative of the formula (I) or a salt thereof The definition of the code and index is as follows: Q is the group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, R 6 S, R 7 (R 8 ) N, R b , R c , R f and R g are each independently hydrogen or (C 1 -C 4 )-alkyl, and R d and R e are respectively Independently hydrogen or (C 1 -C 4 )-alkyl or a carbon atom attached thereto to form a carbonyl group, Rh is hydrogen, (C 1 -C 6 )-alkylsulfonyl, (C 1 -C 4 )-Alkoxy-(C 1 -C 6 )-alkylsulfonyl, phenylsulfonyl, thiophenyl-2-sulfonyl, benzhydryl, benzhydryl-(C 1 -C 6 )-alkyl, benzyl, wherein the last five groups may be monosubstituted by halogen, (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy, if desired Or polysubstituted, R i is (C 1 -C 4 )-alkyl, R k is hydrogen, (C 1 -C 4 )-alkyl, (C 3 -C 7 )-cycloalkyl, A and Y are respectively Independently of oxygen, S(O) n , N(R 3 ), carbonyl or (C 1 -C 4 )-alkylene, which is substituted by n R 9 groups and inserted into n selected from the following The elements in the group: oxygen, S(O) n , N(R 3 ) and carbonyl, X is nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halogen - (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3- C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkenyl, (C 3 - C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkenyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkenyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=) C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, (R 1 ) 2 N (R 1 N(O)C, R 1 (O)C(R 1 )N(O)C, R 2 O(O)C(R 1 )N(O)C, (R 1 ) 2 N(O)C (R 1 )N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N ( O) CO, (R 1 ) 2 N, R 1 (O) C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, ( R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C( R 1 )N(O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-( C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl , (R 1 O)(R 1 )N(O C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 N(O)C-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N (O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 (O)CO -(C 1 -C 6 )-alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 ) N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N- (C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 ) N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-( C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )- Alkyl, R 1 (O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-( C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, Phenyl, heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 The alkyl group, wherein the last six groups are respectively substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate, (C 1 -C) 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 -alkyl, and wherein the heterocyclic group carries n pendant oxy groups, Z is hydrogen, nitro, halogen, cyano, thiocyanamido, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-Alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 - C 6 )-cycloalkenyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6) - alkyl, (C 3 -C 6) - cycloalkenyl, - (C 1 -C 6) - alkyl , Halo - (C 3 -C 6) - cycloalkenyl, - (C 1 -C 6) - alkyl, R 1 (O) C, R 1 (R 1 ON =) C, R 1 O (O) C , (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, (R 1 ) 2 N(R 1 )N(O)C, R 1 (O)C(R 1 N(O)C, R 2 O(O)C(R 1 )N(O)C, (R 1 ) 2 N(O)C(R 1 )N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO, (R 1 ) 2 N, R 1 (O) C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N (O)C(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O) C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, (R 1 O)(R 1 )N(O)C- (C 1 -C 6 )-alkyl, (R 1 ) 2 N(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N ( O) C-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N ( O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S( R 1 )N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 (O)CO-(C 1 -C 6 )-alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 ) -alkyl, (R 1 ) 2 N(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C (R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 ) N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S (R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 - C 6 )-alkyl, R 1 (O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O 2 (O)P-(C 1 -C 6 )-alkyl, phenyl, heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6) - alkyl, heterocyclyl - (C 1 -C 6) - alkyl, where the last-mentioned 6 s-th groups each consisting of each group was selected from a group of substituents: nitro, halogen, cyano, thiocyanate acyl, (C 1 -C 6) - alkyl, halo - (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 O, (R 1 ) 2 N , R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group There are n pendant oxy groups, W is hydrogen, halogen, nitro, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2- C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 - C 7 )-cycloalkyl, halo-(C 3 -C 7 )-cycloalkyl, (C 1 -C 6 )-alkoxy, halo-(C 1 -C 6 )-alkoxy, (C 1 -C 6 )-alkyl-(O) n S-, (C 1 -C 6 )-haloalkyl-(O) n S-, (C 1 -C 6 )-alkoxy-(C 1 -C 4 )-alkyl, (C 1 -C 6 )-alkoxy-(C 1 -C 4 )-haloalkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N, R 1 (O)C(R 1 )N or R 2 (O) 2 S(R 1 )N, R is (C 1 -C 6 )-alkane group, (C 2 -C 6) - alkenyl or (C 2 -C 6) - alkynyl, respectively, each selected from a s-matter of the In the substituted groups: nitro, halogen, cyano, thiocyanate acyl, (C 3 -C 6) - cycloalkyl, R 1 (O) C, R 1 (R 1 ON =) C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 S(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO, (R 1 ) 2 N, R 1 O(R 1 )N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 ) N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S, R 1 C(O)S , R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 ) N(O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S and (R 5 O) 2 (O)P, or (C 3 -C 6 )-ring Alkyl, (C 3 -C 6 )-cycloalkenyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl , heterocyclic group, heterocyclic group-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )- Alkyl, heterocyclyl-O-(C 1 -C 6 )-alkyl, phenyl-N(R 1 )-(C 1 -C 6 )-alkyl, heteroaryl-N(R 1 )- (C 1 -C 6 )-alkyl, hetero Cyclo-N(R 1 )-(C 1 -C 6 )-alkyl, phenyl-S(O) n -(C 1 -C 6 )-alkyl, heteroaryl-S(O) n - (C 1 -C 6 )-alkyl or heterocyclyl-S(O) n -(C 1 -C 6 )-alkyl, each cyclic moiety of which is composed of s selected from the following Group substitution in the group: nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N (O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 S(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO, (R 1 ) 2 N, R 1 O(R 1 )N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S, R 1 C(O)S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O) C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S (R 5 O) 2 (O)P and R 1 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n pendant oxy groups, R' is hydrogen, nitro, halogen, cyanide a group, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-alkenyl, halo-(C 3 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 2 O(O)C, (R 1 ) 2 N(O)C, R 2 S(O)C, (R 1 ) 2 N(S)C, R 1 (R 1 O) N(O)C, R 2 (O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, (R 2 ) 3 Si-(C 1 -C 6 )-alkyl-(O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N ( O)C(R 1 )N(O) 2 S, R 2 (O) 2 S(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, (R 2 ) 3 Si, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, (R 1 O)(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O) C-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 (O)CO-(C 1 -C 6 )-alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, m 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 - C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-( C 1 -C 6 )-alkyl, (R 2 ) 3 Si-(C 1 -C 6 )-alkyl, phenyl, heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )- Alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )-alkyl, of which the last 6 phenyl, heteroaryl and heterocyclic groups are mentioned The cyclic moiety is substituted by s groups selected from the group consisting of nitro, halogen, cyano, sulfur Acyl, (C 1 -C 6) - alkyl, halo - (C 1 -C 6) - alkyl, (C 3 -C 6) - cycloalkyl, R 1 O (O) C , (R 1 2 N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group bears n pendant oxy groups, R 1 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 ) -alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkyne , (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkane -(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkane -O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl , heterocyclic group, heterocyclic group-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )- Alkyl, heterocyclyl-O-(C 1 -C 6 )-alkyl, phenyl-N(R 3 )-(C 1 -C 6 )-alkyl, heteroaryl-N(R 3 )- (C 1 -C 6 )-alkyl, heterocyclyl-N(R 3 )-(C 1 -C 6 )-alkyl, phenyl-S(O) n -(C 1 -C 6 )-alkane Base, heteroaryl-S(O) n -(C 1 -C 6 )-alkyl, heterocyclyl-S(O) n -(C 1 -C 6 )-alkyl, wherein the last 15 groups are respectively composed of s selected from the following groups Substituted in the group: nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 ) -cycloalkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, (R 3 ) 2 N(O) 2 S and R 3 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n pendant oxy groups, and R 2 is (C 1 -C 6 -alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )- Alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )- Cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl , cycloalkyl-(C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl -O- (C 1 -C 6) - alkyl, heterocyclyl -O- (C 1 -C 6) - Group, a phenyl group -N (R 3) - (C 1 -C 6) - alkyl, heteroaryl, -N (R 3) - (C 1 -C 6) - alkyl, a heterocyclic group -N (R 3 )-(C 1 -C 6 )-alkyl, phenyl-S(O) n -(C 1 -C 6 )-alkyl, heteroaryl-S(O) n -(C 1 -C 6 -alkyl,heterocyclyl-S(O) n -(C 1 -C 6 )-alkyl, wherein the last 15 groups are respectively subjected to s groups selected from the group consisting of the following Group substitution: nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkane Base, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, ( R 3 ) 2 N(O) 2 S and R 3 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n pendant oxy groups, R 3 is hydrogen, (C 1 -C 6 ) -alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or phenyl, R 4 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 ) -alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl- (C 1 -C 6 )-alkyl or phenyl, R 5 is hydrogen or (C 1 -C 4 )-alkyl, and R 6 is (C 1 - C 4 )-alkyl or phenyl substituted by m groups selected from the group consisting of halogen, nitro, cyano, (C 1 -C 4 )-alkyl, C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-haloalkoxy, R 7 is hydrogen, (C 1 -C 4 )-alkane Or (C 1 -C 4 )-alkoxy, R 8 is hydrogen or (C 1 -C 4 )-alkyl, or R 7 and R 8 together with the nitrogen atom to which they are attached form 5- or 6- a saturated, partially saturated or unsaturated ring further comprising n heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, and substituted by m groups selected from the group consisting of halogens, Cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-haloalkoxy R 9 is halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-halogen Alkoxy or (C 1 -C 4 )-alkoxy-(C 1 -C 4 )-alkyl, m is 0, 1, 2, 3, 4 or 5, n is 0, 1 or 2, s Is 0, 1, 2 or 3, and t is 0 or 1.

式(I)及下文所示所有化學式中,具有超過2個碳原子之烷基可為直鏈或分支鏈。烷基為例如:甲基、乙基、正-或異丙基、正-、異-、第三-或2-丁基、戊基、己基(如:正己基、異己基及1,3-二甲基丁基)。同樣地,烯基為例如:烯丙基、1-甲基丙-2-烯-1-基、2-甲基-丙-2-烯-1-基、丁-2-烯-1-基、丁-3-烯-1-基、1-甲基-丁-3-烯-1-基及1-甲基-丁-2-烯-1-基。炔基為例如:炔丙基、丁-2-炔-1-基、丁-3-炔-1-基、1-甲基-丁-3-炔-1-基。各例中,多重鍵可位於不飽和基團之任何位置。環烷基為具有3至6個碳原子之碳環狀飽和環系,例如:環丙基、環丁基、環戊基或環己基。同樣地,環烯基為具有3至6個 碳環組員之單環狀烯基,例如:環丙烯基、環丁烯基、環戊烯基及環己烯基,其中雙鍵可位於任何位置。 In the formula (I) and all of the formulas shown below, the alkyl group having more than 2 carbon atoms may be a straight chain or a branched chain. The alkyl group is, for example, methyl, ethyl, n- or isopropyl, n-, i-, tri- or 2-butyl, pentyl, hexyl (eg, n-hexyl, isohexyl, and 1,3- Dimethyl butyl). Similarly, an alkenyl group is, for example, allyl, 1-methylprop-2-en-1-yl, 2-methyl-prop-2-en-1-yl, but-2-en-1-yl , but-3-en-1-yl, 1-methyl-but-3-en-1-yl and 1-methyl-but-2-en-1-yl. The alkynyl group is, for example, propargyl, but-2-yn-1-yl, but-3-yn-1-yl, 1-methyl-but-3-yn-1-yl. In each case, the multiple bond can be located anywhere in the unsaturated group. The cycloalkyl group is a carbon cyclic saturated ring system having 3 to 6 carbon atoms, for example, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group. Similarly, the cycloalkenyl group has 3 to 6 A monocyclic alkenyl group of a carbocyclic group member, for example, a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, and a cyclohexenyl group, wherein the double bond may be located at any position.

鹵素為氟、氯、溴或碘。 Halogen is fluorine, chlorine, bromine or iodine.

雜環基為包含3至6個環原子之飽和、部分飽和或完全不飽和環狀基團,其中1至4個環原子係選自氧、氮及硫所組成群中且可再與苯并環縮合。雜環基為例如:哌啶基、吡咯啶基、四氫呋喃基、二氫呋喃基及氧雜環丁烷基。雜芳基為包含3至6個環原子之芳香系環狀基團,其中1至4個環原子係選自氧、氮及硫所組成群中且可再與苯并環縮合。雜芳基為例如:苯并咪唑-2-基、呋喃基、咪唑基、異唑基、異噻唑基、唑基、吡基、嘧啶基、嗒基、吡啶基、苯并異唑基、噻唑基、吡咯基、吡唑基、噻吩基、1,2,3-二唑基、1,2,4-二唑基、1,2,5-二唑基、1,3,4-二唑基、1,2,4-三唑基、1,2,3-三唑基、1,2,5-三唑基、1,3,4-三唑基、1,2,4-三唑基、1,2,4-噻二唑基、1,3,4-噻二唑基、1,2,3-噻二唑基、1,2,5-噻二唑基、2H-1,2,3,4-四唑基、1H-1,2,3,4-四唑基、1,2,3,4-三唑基、1,2,3,5-三唑基、1,2,3,4-噻三唑基及1,2,3,5-噻三唑基。若基團經多個取代基取代時,其意指經一個或多個相同或相異之上述基團取代。此點同樣適用於由不同原子與元素構成之環系。此時,熟悉此相關技術者咸了解,彼等在標準溫度及壓力條件下不穩定之化合物均不在申請專利範圍內。 A heterocyclic group is a saturated, partially saturated or fully unsaturated cyclic group containing from 3 to 6 ring atoms, wherein one to four ring atoms are selected from the group consisting of oxygen, nitrogen and sulfur and can be further combined with benzo Ring condensation. The heterocyclic group is, for example, piperidinyl, pyrrolidinyl, tetrahydrofuranyl, dihydrofuranyl or oxetane. The heteroaryl group is an aromatic cyclic group containing 3 to 6 ring atoms, wherein 1 to 4 ring atoms are selected from the group consisting of oxygen, nitrogen and sulfur and can be further condensed with a benzo ring. Heteroaryl is, for example, benzimidazol-2-yl, furyl, imidazolyl, iso Azyl, isothiazolyl, Azolyl, pyridyl Base, pyrimidinyl, oxime Base, pyridyl, benzo Azyl, thiazolyl, pyrrolyl, pyrazolyl, thienyl, 1,2,3- Diazolyl, 1,2,4- Diazolyl, 1, 2, 5- Diazolyl, 1,3,4- Diazolyl, 1,2,4-triazolyl, 1,2,3-triazolyl, 1,2,5-triazolyl, 1,3,4-triazolyl, 1,2,4- Triazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,3-thiadiazolyl, 1,2,5-thiadiazolyl, 2H- 1,2,3,4-tetrazolyl, 1H-1,2,3,4-tetrazolyl, 1,2,3,4- Triazolyl, 1, 2, 3, 5- Triazolyl, 1,2,3,4-thiatriazolyl and 1,2,3,5-thiatriazole. If a group is substituted with a plurality of substituents, it is meant to be substituted by one or more of the same or different groups described above. This also applies to ring systems composed of different atoms and elements. At this time, those skilled in the relevant art know that their compounds which are unstable under standard temperature and pressure conditions are not within the scope of patent application.

依據式(I)化合物之性質與所附接之取代基而定,式(I)化合物可能出現立體異構物。若例如:存在一個或多個不對稱取代之碳原子時,其可能出現對映異構物及非對映異構物。當S(O)n基團中之n為1(亞碸)時,亦會出現立體異構物。此 外,磺醯亞胺基或亞磺醯亞胺基之硫原子為對掌性中心。可採用習知分離法,例如:層析分離法,從製法所得之混合物中得到立體異構物。亦可能採用光學活性起始物及/或輔劑進行選擇性反應,選擇性製備立體異構物。本發明亦有關涵括在式(I)中,但未明確出示其立體型式之所有立體異構物,及其混合物。 Depending on the nature of the compound of formula (I) and the attached substituents, stereoisomers may occur in the compounds of formula (I). If, for example, one or more asymmetrically substituted carbon atoms are present, they may be enantiomers and diastereomers. Stereoisomers also occur when n in the S(O) n group is 1 (anthracene). Further, the sulfur atom of the sulfoximine or sulfoximine group is the center of the palm. A stereoisomer can be obtained from a mixture obtained by the conventional method by a conventional separation method such as a chromatographic separation method. It is also possible to selectively react to prepare stereoisomers using optically active starting materials and/or adjuvants. The invention is also related to all stereoisomers of formula (I), but not all of which are not explicitly shown, and mixtures thereof.

式(I)化合物可以形成鹽類。鹽類之形成法可利用鹼作用在彼等帶有酸性氫原子之式(I)化合物(例如:當Ra為羥基或Rh為氫時)。合適鹼類為例如:有機胺類,如:三烷基胺、嗎啉、哌啶或吡啶,及銨、鹼金屬或鹼土金屬氫氧化物、碳酸鹽及碳酸氫鹽,特定言之氫氧化鈉與氫氧化鉀、碳酸鈉與碳酸鉀及碳酸氫鈉與碳酸氫鉀。此等鹽類為其中酸性氫被農業上適用之陽離子置換之化合物,例如:金屬鹽類,特定言之鹼金屬鹽類或鹼土金屬鹽類,尤指鈉鹽類及鉀鹽類,或銨鹽類、與有機胺形成之鹽類或四級銨鹽類,例如:與式[NRR*R**R***]+(其中R、R*、R**及R***分別獨立代表有機基團,特定言之烷基、芳基、芳烷基或烷基芳基)之陽離子形成之鹽類。亦合適者為烷基鋶及烷基氧化鋶鹽類,如:(C1-C4)-三烷基鋶及(C1-C4)-三烷基氧化鋶鹽類。 The compounds of formula (I) can form salts. The salt formation method can utilize a base to act on the compound of the formula (I) having an acidic hydrogen atom (for example, when Ra is a hydroxyl group or Rh is hydrogen). Suitable bases are, for example, organic amines such as trialkylamines, morpholines, piperidines or pyridines, and ammonium, alkali or alkaline earth metal hydroxides, carbonates and hydrogencarbonates, in particular sodium hydroxide With potassium hydroxide, sodium carbonate and potassium carbonate, and sodium hydrogencarbonate and potassium hydrogencarbonate. Such salts are compounds in which acidic hydrogen is replaced by agriculturally applicable cations, such as metal salts, in particular alkali metal or alkaline earth metal salts, especially sodium and potassium salts, or ammonium salts. a salt or a quaternary ammonium salt formed with an organic amine, for example: with the formula [NRR*R**R***] + (wherein R, R*, R** and R*** are independently represented a salt formed by a cation of an organic group, specifically an alkyl group, an aryl group, an arylalkyl group or an alkylaryl group. Also suitable are alkyl hydrazines and alkyl cerium oxide salts such as (C 1 -C 4 )-trialkyl hydrazine and (C 1 -C 4 )-trialkyl cerium oxide salts.

式(I)化合物可藉由在鹼性基團(如,例如:胺基、烷胺基、二烷胺基、哌啶基、嗎啉基或吡啶基)與合適之無機或有機酸(例如:礦物酸類,如:HCl、HBr、H2SO4、H3PO4或HNO3或有機酸類,例如:羧酸類,如:甲酸、乙酸、丙酸、草酸、乳酸或水楊酸,或磺酸類,如:對甲苯磺酸)形成加合物而形成鹽類。此時,該鹽類包含酸之共軛鹼作為陰離子。 The compound of formula (I) may be substituted with a suitable basic or organic acid (for example, an amine group, an alkylamino group, a dialkylamino group, a piperidinyl group, a morpholinyl group or a pyridyl group) (for example). : mineral acids such as: HCl, HBr, H 2 SO 4 , H 3 PO 4 or HNO 3 or organic acids such as carboxylic acids such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid, or sulphur An acid such as p-toluenesulfonic acid forms an adduct to form a salt. At this time, the salt contains an conjugate base of an acid as an anion.

較佳為式(I)化合物中 Q為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基,Rb、Rc、Rf及Rg分別獨立為氫或(C1-C4)-烷基,Rd、Re 分別獨立為氫或(C1-C4)-烷基或與其所附接之碳原子共同形成羰基,Rh 為氫,Ri 為(C1-C4)-烷基,Rk 為氫、(C1-C4)-烷基、(C3-C7)-環烷基,A及Y 分別獨立為氧或(C1-C4)-伸烷基,其係經n個R9基團取代,X 為硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、 R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,Z 為氫、硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基且其中雜環基帶有n個側氧基,W 為氫、鹵素、硝基、氰基、(C1-C6)-烷基、鹵-(C1-C6)- 烷基、(C3-C7)-環烷基、(C1-C6)-烷氧基、(C1-C6)-烷基-(O)nS-、R1O(O)C、(R1)2N、R1(O)C(R1)N或R2(O)2S(R1)N,R 為(C1-C6)-烷基,其係分別經s個選自下列各物所組成群中之基團取代:鹵素、氰基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R2(O)2S(R1)N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S及(R1)2N(O)C(R1)N(O)2S或為(C3-C6)-環烷基,其係分別經s個選自下列各物所組成群中之基團取代:鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C及(R1)2N(O)C,R’ 為氫、硝基、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R2O(O)C、(R1)2N(O)C、R2(O)2S、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基,R1 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基,其中最後述及之9個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R3O(O)C、 (R3)2N(O)C、R3O、(R3)2N、R4(O)nS及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R2 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基,其中最後述及之9個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R3 為氫或(C1-C6)-烷基,R4 為(C1-C6)-烷基,R5 為氫或(C1-C4)-烷基,R9 為鹵素、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基、(C1-C4)-鹵烷氧基或(C1-C4)-烷氧基-(C1-C4)-烷基,n 為0、1或2,s 為0、1、2或3,t 為0或1。特別佳為式(I)化合物中Q為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基,Rb、Rc、Rf及Rg分別獨立為氫或甲基,Rd、Re 為氫或與其所附接之碳原子共同形成羰基,Rh 為氫,Ri 為甲基或乙基,Rk 為氫、甲基或環丙基,A及Y 分別獨立為CH2或CH2CH2,X 為硝基、鹵素、甲基、乙基、正丙基、異丙基、三氟甲基、二氟甲基、氯二氟甲基、二氯氟甲基、三氯甲基、五氟乙基、七氟異丙基、環丙基、甲氧基、乙氧基、甲基硫烷基、甲基亞磺醯基、甲基磺醯基、甲氧基甲基、乙氧基甲基、甲氧基乙基、甲氧基乙氧基甲基、甲基硫甲基、甲基亞磺醯基甲基或甲基磺醯基甲基,Z為氫、硝基、氰基、鹵素、甲基、乙基、正丙基、異丙基、三氟甲基、二氟甲基、氯二氟甲基、二氯氟甲基、三氯甲基、五氟乙基、七氟異丙基、環丙基、甲氧基、乙氧基、甲基硫烷基、甲基亞磺醯基或甲基磺醯基,W 為氫、氯或甲基,R為甲基、乙基或正丙基,R’ 為氫或氰基,t 為0或1。 Preferably, in the compound of formula (I), Q is a group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, and R b , R c , R f and R g are each independently hydrogen or (C 1 -C 4 )-alkyl, and R d and R e are each independently hydrogen or (C 1 -C 4 )- An alkyl group or a carbon atom to which it is attached forms a carbonyl group, Rh is hydrogen, R i is (C 1 -C 4 )-alkyl, R k is hydrogen, (C 1 -C 4 )-alkyl, C 3 -C 7 )-cycloalkyl, A and Y are each independently oxygen or (C 1 -C 4 )-alkylene, which is substituted by n R 9 groups, X is nitro, halogen, cyanide , (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3- C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-( C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 2 N(O)C, R 1 O, (R 1 ) 2 N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O) C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, (R 5 O) 2 (O) P, R 1 (O) C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N- (C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N -(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl , (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, phenyl, hetero Aryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )-alkyl , wherein the last six groups are substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkane , halo-(C 1 -C 6 )-alkyl, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N ( O) 2 S and R 1 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group bears n pendant oxy groups, Z is hydrogen, nitro, halogen, cyano, (C 1 -C 6 -alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkane , halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 O, (R 1 ) 2 N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C( R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 ) N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )- Alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, phenyl , heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )- The alkyl group, wherein the last six groups are respectively substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate , (C 1 -C 6) - alkyl, halo - (C 1 -C 6) - alkyl, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O (O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 )-alkyl and wherein the heterocyclic group carries n pendant oxy groups, W is hydrogen, halogen, nitro, Cyano, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 7 )-cycloalkyl, (C 1 -C 6 )-alkoxy , (C 1 -C 6 )-alkyl-(O) n S-, R 1 O(O)C, (R 1 ) 2 N, R 1 (O)C(R 1 )N or R 2 (O 2 S(R 1 )N, R is (C 1 -C 6 )-alkyl, which is substituted by s groups selected from the group consisting of halogen, cyano, (C 3 ) -C 6 )-cycloalkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O, (R 1 ) 2 N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N (O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S and (R 1 ) 2 N(O) C(R 1 )N(O) 2 S or (C 3 -C 6 )-cycloalkyl, which is substituted by s groups selected from the group consisting of halogens, (C 1 -C 6 )-alkyl, halogen-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C and (R 1 ) 2 N(O)C, R' is hydrogen, nitro, cyano, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 2 O(O)C, (R 1 ) 2 N(O)C, R 2 (O) 2 S, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 is hydrogen, (C 1- C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3- C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-( C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1- C 6 )-alkyl, heterocyclic, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O- (C 1 -C 6 )-alkyl, heterocyclyl-O-(C 1 -C 6 )-alkyl, The 9 groups mentioned in the last are substituted by s groups selected from the group consisting of nitro, halogen, (C 1 -C 6 )-alkyl, halogen-(C 1 -C 6 )-alkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S and R 3 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group bears n pendant oxy groups, R 2 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3- C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, benzene , phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl, heterocyclyl-(C 1 -C 6 ) -alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )-alkyl, heterocyclyl-O-(C 1 -C 6 ) - an alkyl group, wherein the last 9 groups are respectively substituted by s groups selected from the group consisting of nitro, halogen, (C 1 -C 6 )-alkyl, halogen-( C 1 -C 6 )-alkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S and R 3 O- (C 1 -C 6) - alkyl, Wherein heterocyclic group with n oxo, R 3 is hydrogen or (C 1 -C 6) - alkyl, R 4 is (C 1 -C 6) - alkyl, R 5 is hydrogen or (C 1 - C 4 )-alkyl, R 9 is halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-haloalkoxy or (C 1 -C 4 )-alkoxy-(C 1 -C 4 )-alkyl, n is 0, 1 or 2, and s is 0, 1, 2 or 3 , t is 0 or 1. Particularly preferably, in the compound of formula (I), Q is a group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, R b , R c , R f and R g are each independently hydrogen or a methyl group, R d , R e are hydrogen or a carbon atom attached thereto forms a carbonyl group, and Rh is hydrogen, R i Is methyl or ethyl, R k is hydrogen, methyl or cyclopropyl, A and Y are each independently CH 2 or CH 2 CH 2 , X is nitro, halogen, methyl, ethyl, n-propyl, Isopropyl, trifluoromethyl, difluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, pentafluoroethyl, heptafluoroisopropyl, cyclopropyl, methoxy, Ethoxy, methylsulfanyl, methylsulfinyl, methylsulfonyl, methoxymethyl, ethoxymethyl, methoxyethyl, methoxyethoxymethyl, Methylthiomethyl, methylsulfinylmethyl or methylsulfonylmethyl, Z is hydrogen, nitro, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, tri Fluoromethyl, difluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, pentafluoroethyl, heptafluoroisopropyl, cyclopropyl, methoxy, ethoxy, A Alkylsulfanyl, methylsulfinyl or methylsulfonyl, W is hydrogen, chlorine or methyl, R is methyl, ethyl N-propyl, R 'is hydrogen or cyano group, t is 0 or 1.

根據本發明式(I)化合物可從相應之式(I-硫醚)硫醚類製備(反應圖1)。因此,使用例如:氰醯胺及氧化劑(二乙酸氧碘苯、次氯酸鈉或N-溴琥珀醯亞胺)轉化硫醚形成相應之亞磺醯亞胺,其再氧化轉化成磺醯亞胺。適於氧化形成磺醯亞胺之氧化劑為如,例如:間氯過苯甲酸、過錳酸鈉、或過碘酸鈉與三氯化釕之混合物。可例如:由亞碸使用疊氮化鈉及硫酸製得NH-磺醯亞胺,並使用試劑(如,例如:溴化氰、醯基氯或酸酐、氯甲酸酯、硝酸或其他化合物)於氮原子官能基化。N-磺酸化亞磺醯亞胺氧化成相應磺醯亞胺之過程可使用例如:氫進行。或者,亞碸可轉化成N-醯基化或N-磺酸化磺醯亞胺。分別可再裂解該羧醯胺或磺醯胺,形成NH-磺醯亞胺。此等從硫醚製備亞磺醯亞胺及磺醯亞胺之合成法或從亞碸製備磺醯亞胺之合成法、或衍化亞磺醯亞胺及磺醯亞胺(亦指NH-磺醯亞胺)之方法特別說明於例如:Bolm,C.Org.Lett.2004,6,1305;Bolm,C.Org.Lett.2007,9,3809;Bolm,C.Synthesis 2010,17,2922;Bolm,C.Adv.Synth.Catal.2010,352,309;WO 2007/095229 A1、WO 2008/141843 A1、WO 2008/097235 A1、US 2008/0207910 A1、US 2008/0194634 A1及US 2010/0056534 A1。 The compounds of formula (I) according to the invention can be prepared from the corresponding formula (I-thioether) thioethers (reaction Figure 1). Thus, the thioether is converted using the cyanamide and the oxidizing agent (oxyiodobenzene diacetate, sodium hypochlorite or N-bromosuccinimide) to form the corresponding sulfoximine, which is reoxidized to the sulfoximine. The oxidizing agent suitable for the oxidation to form the sulfoximine is, for example, m-chloroperbenzoic acid, sodium permanganate, or a mixture of sodium periodate and antimony trichloride. For example, NH-sulphonimine can be prepared from sodium azide using sodium azide and sulfuric acid, and reagents such as, for example, cyanogen bromide, decyl chloride or anhydride, chloroformate, nitric acid or other compounds can be used. Functionalized with a nitrogen atom. The oxidation of the N-sulfonated sulfinimide to the corresponding sulfonimide can be carried out using, for example, hydrogen. Alternatively, the hydrazine can be converted to N-thiolated or N-sulfonated sulfonimide. The carboxamide or sulfonamide can be re-cleaved separately to form NH-sulfonimide. The synthesis of sulfoximine and sulfonimide from thioether or the synthesis of sulfonimide from hydrazine, or the derivatization of sulfoximine and sulfonimide (also referred to as NH-sulfonate) The method of quinone imine) is specifically described, for example, in Bolm, C. Org. Lett. 2004, 6, 1305; Bolm, C. Org. Lett. 2007, 9, 3809; Bolm, C. Synthesis 2010, 17, 2922; Bolm, C. Adv. Synth. Catal. 2010, 352, 309; WO 2007/095229 A1, WO 2008/141843 A1, WO 2008/097235 A1, US 2008/0207910 A1, US 2008/0194634 A1 and US 2010/0056534 A1.

若需要時,必需在此等合成順序中使用保護基來達成充份選擇性。特定言之NH-磺醯亞胺之官能化原則上會與醯胺態氮原子上之類似官能化競爭。最適當製程將依相關之取代型態而定。 If necessary, it is necessary to use a protecting group in these synthetic sequences to achieve sufficient selectivity. In particular, the functionalization of NH-sulfonimide will in principle compete with similar functionalization on the guanamine nitrogen atom. The most appropriate process will depend on the type of substitution that is relevant.

式(I-硫醚)化合物及式(I-亞碸)化合物係已知者且說明於例如:WO 2003/014071 A1、WO 2008/125214 A1、WO 2009/149806 A1、WO 2011012247 A1、WO 2011012247 A1、EP 0 609 798 A1及EP 0 625 508 A1。 The compounds of the formula (I-thioether) and the compounds of the formula (I-Athene) are known and described, for example, in WO 2003/014071 A1, WO 2008/125214 A1, WO 2009/149806 A1, WO 2011012247 A1, WO 2011012247 A1, EP 0 609 798 A1 and EP 0 625 508 A1.

可能適宜改變反應步驟順序。磺醯亞胺及特定言之亞磺醯亞胺在某些條件下之穩定度不足(Bolm,C.Adv.Synth.Catal.2010,352,309),因此可能宜先在硫醚階段合成苯甲醯基衍生物(如反應圖1所示),並僅在合成過程結束時從硫醚產生亞磺醯亞胺或磺醯亞胺。然而,若具有充份穩定度時,依取代型態而定,亦可能宜先在苯甲酸階段(或甚至在更早階 段)從硫醚產生亞磺醯亞胺或磺醯亞胺,然後僅轉化苯甲酸形成其苯甲醯基衍生物(反應圖2)。由苯甲酸形成許多種不包含亞磺醯亞胺基或磺醯亞胺基之結構之苯甲醯基衍生物之轉化法係已知且說明於例如:WO 2003/014071 A1、WO 2008/125214 A1、WO 2009/149806 A1、WO 2011012247 A1、WO 2011012247 A1、EP 0 609 798 A1及EP 0 625 508 A1。依據取代型態而定,可能適宜採用這種途徑形成根據本發明之式(I)化合物。 It may be appropriate to change the sequence of reaction steps. Sulfonimide and, in particular, sulfinimide have insufficient stability under certain conditions (Bolm, C. Adv. Synth. Catal. 2010, 352, 309), so it may be appropriate to first synthesize benzamidine in the thioether phase. A base derivative (as shown in Figure 1) and produces sulfinimide or sulfonimide from the thioether only at the end of the synthesis process. However, if it has sufficient stability, depending on the substitution type, it may be preferable to first in the benzoic acid stage (or even in the earlier stage). Paragraph) The production of sulfinimide or sulfonimide from thioether, followed by conversion of only benzoic acid to form its benzamidine derivative (reaction Figure 2). A conversion process for the formation of a plurality of benzamidine derivatives of a structure which does not comprise a sulfinimide group or a sulfonimide group from benzoic acid is known and described, for example, in WO 2003/014071 A1, WO 2008/125214 A1, WO 2009/149806 A1, WO 2011012247 A1, WO 2011012247 A1, EP 0 609 798 A1 and EP 0 625 508 A1. Depending on the type of substitution, it may be appropriate to employ such a route to form a compound of formula (I) according to the invention.

某些例子中,可能適合改用苯甲酸之衍生物替代游離苯甲酸來進行反應。有時候官能基之安定性僅足以在酸性或鹼性介質中操作,亦即僅可使用游離苯甲酸或僅可使用其鹽。有時候適合採用如:甲酯或乙酯之酯類。通常第三丁基酯足 以在立體上有效遮蔽羧基對抗親核性試劑,且其很容易在酸性介質中裂解(T.W.Greene,P.G.M.Wuts之”有機合成法之保護基(Protective Groups in Organic Synthesis)”,第2版,John Wiley & Sons,Inc.1991,p.227 ff.)。亦適合採用比羧基更穩定之基團,但其亦應很容易再轉化回游離羧酸。此等基團包括例如:唑啉類(T.W.Greene,P.G.M.Wuts之”有機合成法之保護基(Protective Groups in Organic Synthesis)”,第2版,John Wiley & Sons,Inc.1991,p.265 ff.;Z.Hell等人之Tetrahedron Letters 43(2002),3985-3987)。 In some instances, it may be appropriate to use a derivative of benzoic acid instead of free benzoic acid to carry out the reaction. Sometimes the stability of the functional group is only sufficient to operate in an acidic or basic medium, i.e., only free benzoic acid or only salts thereof may be used. Sometimes it is suitable to use esters such as methyl or ethyl esters. Usually, the third butyl ester is sufficient to stereoscopically mask the carboxyl group against the nucleophilic reagent, and it is easily cleaved in an acidic medium (TW Greene, PGM Wuts, "Protective Groups in Organic Synthesis", 2nd edition, John Wiley & Sons, Inc. 1991, p. 227 ff.). It is also suitable to use a group which is more stable than the carboxyl group, but it should also be easily converted back to the free carboxylic acid. Such groups include, for example: Orthochrome (TW Greene, PGM Wuts, "Protective Groups in Organic Synthesis", 2nd ed., John Wiley & Sons, Inc. 1991, p. 265 ff.; Z. Hell et al. Tetrahedron Letters 43 (2002), 3985-3987).

上述式(IIa)及(IIb)之苯甲酸及其乙酯、甲酯及苯甲醯基氯為新穎者且由式(II)代表。 The benzoic acid of the above formulas (IIa) and (IIb) and its ethyl ester, methyl ester and benzhydryl chloride are novel and represented by the formula (II).

式(II)中,Q*為羥基、乙氧基、甲氧基或氯。R、R'、X、W、Z及t具有式(I)之定義。式(II)化合物特別適合製備根據本發明式(I)化合物。式(II)化合物亦形成本發明主題之一部份。 In the formula (II), Q* is a hydroxyl group, an ethoxy group, a methoxy group or a chlorine group. R, R', X, W, Z and t have the definition of formula (I). The compounds of the formula (II) are particularly suitable for the preparation of the compounds of the formula (I) according to the invention. The compounds of formula (II) also form part of the subject matter of the present invention.

各反應混合物之操作法通常採用已知方法進行,例如:結晶法、水性萃取操作法、層析法或此等方法之組合。 The operation of each reaction mixture is usually carried out by a known method such as a crystallization method, an aqueous extraction operation method, a chromatography method or a combination of these methods.

可根據上述反應合成之式(I)化合物及/或其鹽類之集合亦可依平行方式製備,其可採用手動方式或完全自動化方式進行。此時,可能例如:使反應製程、操作法或產物或中間物之純化法自動化。總言之,此製程可從例如:D.Tiebes於”組合化學-合成法、分析法、篩選法(Combinatorial Chemistry-Synthesis,Analysis,Screening(Günther Jung編輯),Wiley 1999,第1至34頁”中之說明了解。 The collection of the compound of the formula (I) and/or its salts which can be synthesized according to the above reaction can also be prepared in a parallel manner, which can be carried out manually or completely automatically. At this point, it may be possible, for example, to automate the reaction process, the process or the purification of the product or intermediate. In summary, this process can be obtained, for example, from D. Tiebes in "Combination Chemistry - Synthesis, Analysis, Screening (Combinatorial) Understanding the explanation in Chemistry-Synthesis, Analysis, Screening (edited by Günther Jung, Wiley 1999, pages 1 to 34).

商業上有許多設備可用於平行進行反應製程及操作,例如:卡氏反應槽(Calpyso reaction blocks)(來自Barnstead International,Dubuque,Iowa 52004-0797,USA),或反應站(來自Radleys,Shirehill,Saffron Walden,Essex,CB 11 3AZ,英國)或多探針自動化工作站(MultiPROBE Automated Workstations)(來自Perkin Elmar,Waltham,Massachusetts 02451,USA)。可特別採用層析設備(例如:來自ISCO,Inc.,4700 Superior Street,Lincoln,NE 68504,USA)平行進行製備過程中所產生式(I)化合物及其鹽類或中間物之純化。 There are many commercially available equipment for parallel reaction processes and operations, such as: Calpyso reaction blocks (from Barnstead International, Dubuque, Iowa 52004-0797, USA), or reaction stations (from Radleys, Shirehill, Saffron). Walden, Essex, CB 11 3AZ, UK) or MultiPROBE Automated Workstations (from Perkin Elmar, Waltham, Massachusetts 02451, USA). Purification of the compounds of formula (I) and their salts or intermediates produced during the preparation can be carried out in parallel using chromatographic equipment (for example: from ISCO, Inc., 4700 Superior Street, Lincoln, NE 68504, USA).

上列進行模組化製程之設備中,每一輪程序係自動化進行,但每輪程序之間必需手動進行。此作法即不需要利用藉由例如:自動化工具操作之相關自動模組之部份或完全集成自動化系統。此等自動化系統可得自例如:Caliper,Hopkinton,MA 01748,USA。 In the above-mentioned modular process, each round of the program is automated, but each round must be manually performed. This does not require the use of a partially or fully integrated automation system with associated automatic modules operated by, for example, automated tools. Such automated systems are available, for example, from Caliper, Hopkinton, MA 01748, USA.

個別或數個合成步驟之效能可藉助於利用以聚合物為擔體之試劑/清除劑樹脂。該專業文獻說明一系列實驗程序,例如:ChemFiles,Vol.4,No.1,“溶液相合成法之以聚合物為擔體之清除劑與樹脂(Polymer-Supported Scavengers and Reagents for Solution-Phase Synthesis)(Sigma-Aldrich)。 The effectiveness of individual or several synthetic steps can be achieved by utilizing a polymer-supported reagent/scavenger resin. This professional literature describes a series of experimental procedures, for example: ChemFiles, Vol. 4, No. 1, "Polymer-Supported Scavengers and Reagents for Solution-Phase Synthesis ) (Sigma-Aldrich).

除了本文說明之方法外,式(I)化合物及其鹽類之製法可完全或部份採用固相擔體方法進行。基於此目的,讓合成法或配合相關製程之合成法之個別中間物或所有中間物結合在合成樹脂上。固相擔體合成法已詳細說明於專業文獻中,例如:Barry A.Bunin之“組合指數(The Combinatorial Index)”, Academic Press,1998及”組合化學-合成法、分析法、篩選法(Combinatorial Chemistry-Synthesis,Analysis,Screening(Günther Jung編輯),Wiley 1999”。利用固相擔體合成法可以進行一系列自文獻中已知之方法,其同樣可依手動或自動化方式進行。例如:該反應可利用IRORI技術,於來自Nexus Biosystems,12140 Community Road,Poway,CA92064,USA之微反應器中進行。 In addition to the methods described herein, the compounds of formula (I) and salts thereof can be prepared, in whole or in part, by solid phase support. For this purpose, the synthesis or the individual intermediates or all intermediates of the synthesis of the relevant processes are combined on the synthetic resin. The solid phase support synthesis method has been described in detail in the professional literature, for example: Barry A. Bunin's "The Combinatorial Index", Academic Press, 1998 and "Combined Chemistry-Synthesis, Analysis, Screening (Combinatorial Chemistry-Synthesis, Analysis, Screening (Günther Jung, ed.), Wiley 1999". A series of solid-phase support synthesis methods can be used in the literature. Known methods can also be carried out manually or automatically. For example, the reaction can be carried out in a microreactor from Nexus Biosystems, 12140 Community Road, Poway, CA 92064, USA using IRORI technology.

於固相及液相中進行之個別或數個合成步驟可藉助於微波技術進行。一系列實驗法已說明於專業文獻中,例如:”有機與醫學化學之微波法(Microwaves in Organic and Medicinal Chemistry)(C.O.Kappe及A.Stadler編輯),Wiley,2005”。 The individual or several synthetic steps carried out in the solid phase and in the liquid phase can be carried out by means of microwave technology. A series of experimental methods have been described in the professional literature, for example: "Microwaves in Organic and Medicinal Chemistry" (edited by C. O. Kappe and A. Stadler, Wiley, 2005).

根據本文所說明製法可製備呈集成型式之式(I)化合物及其鹽類,其稱為集合庫。本發明亦有關一種包含至少兩種式(I)化合物及其鹽類之集合庫。 Compounds of formula (I) and salts thereof, which are referred to as pools, can be prepared according to the procedures described herein. The invention also relates to a collection library comprising at least two compounds of the formula (I) and salts thereof.

根據本發明式(I)化合物(及/或其鹽類)(下文中統稱為「根據本發明化合物」)具有優異除草活性,可對抗影響經濟重要性之廣譜單子葉與雙子葉一年生有害植物。該等活性物質亦可有效對抗會從根莖、初生主根或其他多年生器官長出幼芽而且很難控制之多年生有害植物。 The compound of the formula (I) (and/or its salts) according to the invention (hereinafter collectively referred to as "the compound according to the invention") has excellent herbicidal activity against a broad-spectrum monocotyledonous and dicotyledonous annual harmful plant which affects economic importance. . These active substances are also effective against perennial harmful plants that grow out of the roots, primary roots or other perennial organs and are difficult to control.

本發明因此亦有關一種控制不要之植物或調節植物生長(較佳係作物)之方法,其中施用一或多種根據本發明化合物(群)至植物(例如:有害植物,如:單子葉或雙子葉雜草或不需要之作物植株)、種子(例如:穀粒、種子或營養性繁殖株如:塊莖或帶芽之幼枝)或有植物生長之區域(例如:栽種區域)。本文中,根據本發明化合物可在例如:種植前(若適合 時亦可混入土壤中)、出土前或出土後施用。可利用根據本發明化合物控制之單子葉與雙子葉雜草群之個別代表性實例可述及下列(但無意限制某些品種)。 The invention therefore also relates to a method of controlling unwanted plants or regulating plant growth, preferably crops, wherein one or more compounds (groups) according to the invention are applied to plants (for example: harmful plants, such as monocotyledons or dicotyledons) Weeds or unwanted crop plants), seeds (eg grain, seeds or vegetative propagation plants such as: tubers or young shoots with buds) or areas where plants are grown (eg planting areas). Herein, the compound according to the invention can be, for example, before planting (if suitable It can also be mixed into the soil, applied before or after excavation. The individual representative examples of monocotyledonous and dicotyledonous weed populations which may be controlled by the compounds according to the invention may be mentioned below (but are not intended to limit certain varieties).

單子葉有害植物類屬:擬硬皮橘(Aegilops)、小麥草(Agropyron)、糠穗(Agrostis)、看麥娘(Alopecurus)、Apera、烏麥(Avena)、臂形草(Brachiaria)、雀麥(Bromus)、疾藜菜(Cenchrus)、鴨拓草(Commelina)、狗牙根(Cynodon)、莎草(Cyperus)、指梳草(Dactyloctenium)、馬唐(Digitaria)、野稗(Echinochloa)、藺草(Eleocharis)、牛筋草(Eleusine)、畫眉草(Eragrostis)、鳴子稗(Eriochloa)、牧場草(Festuca)、飄拂草(Fimbristylis)、異藥花(Heteranthera)、白茅(Imperata)、鴨嘴草(Ischaemum)、畔茅(Leptochloa)、毒麥(Lolium)、雨久花(Monochoria)、稷(Panicum)、雀稗(Paspalum)、草蘆(Phalaris)、梯牧草(Phleum)、長齒草(Poa)、牛鞭草(Rottboellia)、慈姑(Sagittaria)、蓆草(Scripus)、莠草(Setaria)、高梁(Sorghum)。 Monocotyledonous harmful plant genus: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Finch Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Apis (Ischaemum), Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Teeth Poa), Rottboellia, Sagittaria, Scripus, Setaria, Sorghum.

雙子葉雜草類屬:苘麻(Abutilon)、莧(Amaranthus)、豚草(Ambrosia)、錦葵(Anoda)、羅馬加密列花(Anthemis)、糙葉樹(Aphanes)、茵陳蒿(Artemisia)、濱藜(Atriplex)、雛菊(Bellis)、鬼針草(Bidens)、薺菜(Capsella)、大薊(Carduus)、山扁豆(Cassia)、矢草菊(Centaurea)、藜(Chenopodium)、薊(Cirsium)、三色旋花(Convolvulus)、曼陀羅花(Datura)、跳舞草(Desmodium)、次酸模(Emex)、大橙黃草(Erysimum)、大戟(Euphorbia)、鼬瓣花(Galeopsis)、牛膝菊(Galinsoga)、豬殃殃(Galium)、木僅(Hibiscus)、甘藷(Ipomoea)、地膚(Kochia)、野芝麻(Lamium)、獨行菜(Lepidium)、陌上菜(Lindernia)、西洋甘菊(Matricaria)、薄荷(Mentha)、山藍(Mercurialis)、粟米 草(Mullugo)、勿忘草(Myosotis)、罌粟(Papaver)、牽牛(Pharbitis)、車前草(Plantago)、蓼(Polygonum)、馬齒莧(Portulaca)、毛茛(Ranunculus)、蘿蔔(Raphanus)、焊菜(Rorippa)、莭莭草(Rotala)、酸模(Rumex)、豬毛菜(Salsola)、瓜葉菊(Senecio)、田菁(Sesbania)、午時花(Sida)、白芥(Sinapis)、茄(Solanum)、苦苣菜(Sonchus)、尖瓣花(Sphenoclea)、繁縷(Stellaria)、蒲公英(Taraxacum)、遏藍菜(Thlaspi)、三葉草(Trifolium)、蕁麻(Urtica)、玄參(Veronica)、菫菜(Viola)、苔耳(Xanthium)。 Dicotyledonous weeds: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia ), Atriplex, Bearis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, 蓟(Cirsium), Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Corn Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Welded Vegetables Rorippa), Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum , Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Amaranth (Viola), Xanthium.

若根據本發明化合物在萌芽前先施用在土壤表面上時,可以完全防止雜草幼苗出土或防止雜草生長直到其到達子葉階段為止,但隨後可阻止其生長,3至4週後即完全死亡。 If the compound according to the invention is applied to the soil surface prior to germination, the weed seedlings can be completely prevented from being exhumed or prevented from growing until they reach the cotyledon stage, but then the growth can be prevented, and the death is complete after 3 to 4 weeks. .

當在出土後施用活性物質至綠色植株上時,即在處理後停止生長,讓有害植物停留在施用時之生長階段或在一段時間後完全死亡,因此可以在早期並持續消除對作物植株不利之雜草競爭。 When the active substance is applied to the green plant after excavation, that is, the growth is stopped after the treatment, the harmful plant stays in the growth stage at the time of application or completely dies after a period of time, so that it is possible to eliminate the disadvantage of the crop plant early and continuously. Weed competition.

雖然根據本發明化合物對單子葉與雙子葉雜草展現優異之除草活性,但對經濟重要性之作物,例如:雙子葉作物類屬:花生(Arachis)、甜菜(Beta)、蕓苔(Brassica)、甜瓜(Cucumis)、南瓜(Cucurbita)、向日葵(Helianthus)、胡蘿蔔(Daucus)、大豆(Glycine)、草棉(Gossypium)、甘藷(Ipomoea)、萵苣(Lactuca)、亞麻(Linum)、番茄(Lycopersicon)、煙草(Nicotiana)、菜豆(Phaseolus)、豌豆(Pisum)、茄(Solanum)、蠶豆(Vicia),或單子葉作物類屬:蔥(Allium)、鳳梨(Ananas)、蘆筍(Asparagus)、烏麥(Avena)、大麥(Hordeum)、稻(Oryza)、稷(Panicum)、甘蔗(Saccharum)、黑麥(Secale)、高梁 (Sorghum)、硬粒小麥(Triticale)、小麥(Triticum)、玉米(Zea)(特定言之玉米(Zea)與小麥(Triticum))之傷害則僅達不顯著之程度,或完全沒有傷害,其係依根據本發明各化合物之結構及施用率而定。其係本發明化合物極適用於選擇性控制作物(如:農業上有用作物或觀賞植物)中不要之植株生長之原因。 Although the compounds according to the invention exhibit excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, economically important crops, for example: dicotyledonous crops: Arachis, Beta, Brassica , Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Tomato (Lycopersicon) ), Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or Monocotyledonous genus: Allium, Ananas, Asparagus, Uganda Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum (Sorghum), Triticale, Triticum, Zea (Zea) and Wheat (Triticum) are only insignificant or completely harmless. It depends on the structure and application rate of each compound according to the present invention. The compounds of the present invention are highly suitable for the selective control of the growth of unwanted plants in crops such as agriculturally useful crops or ornamental plants.

此外,根據本發明化合物(依其各結構及施用率而定)對作物植株具有優異之生長調節性質。其以調節方式參與植物之代謝作用,因此可用於依靶向方式影響植物組成,及促進採收,如,例如:啟動脫水及阻礙生長。此外,其亦適合一般控制及抑制不要之營養性生長,不會在過程中破壞植物。抑制營養性生長之作法在許多單子葉及雙子葉作物中扮演重要角色,因為例如:可藉以減少或完全預防倒伏。 Furthermore, the compounds according to the invention (depending on their structure and application rate) have excellent growth regulating properties for crop plants. It participates in the metabolism of plants in a regulated manner and can therefore be used to influence plant composition in a targeted manner and to facilitate harvesting, such as, for example, initiating dehydration and hindering growth. In addition, it is also suitable for general control and suppression of unwanted vegetative growth without destroying plants in the process. The practice of inhibiting vegetative growth plays an important role in many monocotyledonous and dicotyledonous crops because, for example, it is possible to reduce or completely prevent lodging.

基於其除草及調節植物生長性質,活性物質亦可用於基因改造作物或經過傳統誘變法改造之植物中控制有害植物。通常,轉殖基因植物之特徵在於特別有利之性質,例如:對某些農藥(主要針對某些除草劑)之抗性、對植物病害或引起植物病害之生物體(如:某些昆蟲或微生物,如:真菌、細菌或病毒)之抗性。其他特殊性質係有關例如:採收材料之產量、品質、儲存性、組成物及特定組成份。因此,具有提高之澱粉含量或經改造之澱粉品質之轉殖基因植物或彼等具有不同脂肪酸酸組成物之採收材料之轉殖基因植物係已知者。 Active substances can also be used to control harmful plants in genetically modified crops or plants modified by conventional mutagenesis based on their herbicidal and modulating plant growth properties. In general, genetically modified plants are characterized by particularly advantageous properties, such as resistance to certain pesticides (primarily for certain herbicides), to plant diseases or to organisms that cause plant diseases (eg certain insects or microorganisms) Resistance to, for example, fungi, bacteria or viruses. Other special properties relate to, for example, the yield, quality, storage, composition and specific composition of the harvested material. Thus, transgenic plants having an increased starch content or modified starch quality or those having a harvested material having different fatty acid acid compositions are known.

根據本發明化合物或其鹽類較佳係用在具經濟重要性之有用作物之轉殖基因植物與觀賞植物,例如:穀類,如:小麥、大麥、裸麥、燕麥、高粱、及小米、稻、樹薯與玉米,或甜菜、棉花、大豆、油菜、馬鈴薯、番茄、豌豆、及其他蔬菜等作物。根據本發明化合物較佳係作為除草劑,用於已 對除草劑之植物毒性效應具有抗性或經過重組方式而具有抗性之有用作物中。 The compound according to the present invention or a salt thereof is preferably used for the transfer of genetically important plants and ornamental plants of economically important crops, such as cereals such as wheat, barley, rye, oats, sorghum, and millet, rice. , cassava and corn, or crops such as beets, cotton, soybeans, canola, potatoes, tomatoes, peas, and other vegetables. The compound according to the invention is preferably used as a herbicide for It is a useful crop that is resistant to phytotoxic effects of herbicides or resistant to recombinant methods.

相較於現有植物,產生具有改造性質之新穎植物之常用方式為例如:傳統育種法及突變株形成法。或者,可藉助於重組法產生具有改造性質之新穎植物(參見例如:EP-A-0221044、EP-A-0131624)。例如:下文說明幾種例子:- 目的在於改造植物所合成澱粉之作物之重組改造法(例如:WO 92/11376、WO 92/14827、WO 91/19806),- 對某些固殺草(glufosinate)類(參見例如:EP-A-0242236、EP-A-242246)或嘉磷塞(glyphosate)類(WO 92/00377)或磺醯脲類(EP-A-0257993、US-A-5013659)除草劑具有抗性之轉殖基因作物,- 可以產生蘇雲金芽孢桿菌(Bacillus thuringiensis)毒素(Bt毒素)之轉殖基因作物,例如:棉花,使植物對某些有害生物具有抗性(EP-A-0142924、EP-A-0193259),- 具有改造之脂肪酸組成之轉殖基因作物(WO 91/13972),- 具有新穎之組成份或二次代謝物(例如:新穎之植物防禦素)之基因改造作物,其會提高病害抗性(EPA 309862、EPA0464461),- 減少光呼吸作用而提高產量及提高逆境壓力抗性之基因改造植物(EPA 0305398),- 產生具有醫藥或診斷重要性之蛋白質之轉殖基因作物("分子醫藥農場(molecular pharming)"),- 其特徵在於提高產量或改良品質之轉殖基因作物,- 其特徵在於組合例如:上述新穎性質("多價轉基因作物")之轉殖基因作物。 Common methods for producing novel plants having engineered properties compared to existing plants are, for example, conventional breeding methods and mutant strain formation methods. Alternatively, novel plants with engineered properties can be produced by means of recombinant methods (see for example: EP-A-0221044, EP-A-0131624). For example, several examples are described below: - Recombinant modification of crops designed to modify starches synthesized by plants (eg: WO 92/11376, WO 92/14827, WO 91/19806), - for certain snails (glufosinate) ) (see for example: EP-A-0242236, EP-A-242246) or glyphosate (WO 92/00377) or sulfonylureas (EP-A-0257993, US-A-5013659) Herbicide-resistant, transgenic crops, which can produce transgenic crops of Bacillus thuringiensis toxin (Bt toxin), such as cotton, which make plants resistant to certain pests (EP-A) -0142924, EP-A-0193259), - Transgenic crops with engineered fatty acid composition (WO 91/13972), - genes with novel components or secondary metabolites (eg novel plant defensins) Modification of crops, which increase disease resistance (EPA 309862, EPA0464461), genetically modified plants that reduce photorespiration and increase yield and stress resistance to stress (EPA 0305398), producing proteins of medical or diagnostic importance Transgenic crops ("molecular pharming"), - A genetically modified crop characterized by increased yield or improved quality, characterized by a combination of, for example, a genetically modified crop of the above novel nature ("multivalent transgenic crop").

用於產生具有改造性質之新穎轉殖基因植物之許多種分子生物技術係原則上已知者;參見例如:I.Potrykus及G.Spangenberg(編輯)之”植物之基因轉殖(Gene Transfer to Plants),Springer Lab Manual(1995),Springer Verlag Berlin,Heidelberg.或Christou之"植物科學趨勢(Trends in Plant Science)"1(1996)423-431)。 Many molecular biotechnology systems for the production of novel transgenic plants with engineered properties are known in principle; see, for example: I. Potrykus and G. Spangenberg (ed.) "Gene Transfer to Plants" ), Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg. or Christou, "Trends in Plant Science" 1 (1996) 423-431).

為了進行此重組操作法,可能引進核酸分子至質體中,可以進行誘變法或利用DNA序列之重組法改造序列。例如:可以進行鹼基取代法、可移除部份序列、或藉助於標準方法添加天然或合成之序列。為了彼此連接DNA片段,可以在片段上添加適體或連接體;參見例如:Sambrook等人之1989,分子選殖法,實驗手冊(Molecular Cloning,A Laboratory Manual),第2版,Cold Spring Harbor Laboratory Press,Cold Spring Harbor,NY;或Winnacker之"基因與純系(Gene und Klone)",VCH Weinheim第2版,1996。 In order to carry out this recombination method, it is possible to introduce a nucleic acid molecule into a plastid, and a mutagenesis method or a recombinant method using a DNA sequence can be used to engineer a sequence. For example, base substitution methods, removable partial sequences, or addition of natural or synthetic sequences by standard methods can be performed. In order to connect DNA fragments to each other, an aptamer or a linker can be added to the fragment; see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; or Winnacker, "Gene und Klone", VCH Weinheim 2nd Edition, 1996.

可例如:藉由至少一種相應之反義RNA、有義RNA之表現來達成共同壓制之效應或藉由至少一種相應之建構核酶(其專一性裂解上述基因產物之轉錄本)之表現,產生具有降低基因產物活性之植物細胞。其作法可先使用包含基因產物之所有編碼序列(包括任何可能存在之側接序列)之DNA分子或僅包含部份編碼序列之DNA分子,該等部份編碼序列之長度應足以在細胞中產生反義效應。亦可能使用與基因產物之編碼序列具有高度同質性,但不完全相同之DNA序列。 For example, the effect of co-suppression can be achieved by the expression of at least one corresponding antisense RNA, sense RNA, or by the performance of at least one correspondingly constructed ribozyme, which specifically cleaves the transcript of the above gene product, A plant cell having reduced gene product activity. It may be preceded by the use of a DNA molecule comprising all of the coding sequences of the gene product (including any flanking sequences that may be present) or a DNA molecule comprising only a portion of the coding sequence, the length of which is sufficient to produce in the cell. Antisense effect. It is also possible to use DNA sequences that are highly homologous, but not identical, to the coding sequence of the gene product.

當植物中表現核酸分子時,所合成之蛋白質可位於植物細胞之任何間隔中。然而,為了定位在特定間隔內,可以例如:連接編碼區與DNA序列,以確保定位在特定間隔內。此 等序列係熟悉此相關技術者已知者(參見例如:Braun等人之EMBO J.11(1992),3219-3227;Wolter等人之Proc.Natl.Acad.Sci.USA 85(1988),846-850;Sonnewald等人之Plant J.1(1991),95-106)。核酸分子亦可表現在植物細胞之細胞器中。 When a nucleic acid molecule is expressed in a plant, the synthesized protein can be located in any interval of the plant cell. However, for positioning within a particular interval, for example, the coding region and DNA sequence can be ligated to ensure localization within a particular interval. this The sequence is known to those skilled in the relevant art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227; and Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846 -850; Sonnewald et al., Plant J. 1 (1991), 95-106). Nucleic acid molecules can also be expressed in organelles of plant cells.

轉殖基因細胞可利用已知技術再生,產生完整植物。原則上,轉殖基因植物可為任何植物品種,亦即單子葉或雙子葉植物。 Transgenic gene cells can be regenerated using known techniques to produce whole plants. In principle, the transgenic plant can be any plant species, ie monocotyledonous or dicotyledonous.

因此,可得到之轉殖基因植物具有因同源性(=天然)基因或基因序列之過度表現、壓制或抑制或因異源性(=外來)基因或基因序列之表現之結果所致之改造性質特徵。 Thus, the resulting transgenic plants have a transformation due to the overexpression, suppression or inhibition of homologous (=natural) genes or gene sequences or the results of heterologous (=foreign) genes or gene sequences. Nature characteristics.

根據本發明化合物較佳用於對以下物質具有抗性之轉殖基因作物:生長調節劑(如,例如:汰克草(dicamba));或抑制植物必要酵素之除草劑(例如:乙醯乳酸合成酶(ALS)、EPSP合成酶、麩醯胺合成酶(GS)或羥苯基丙酮酸二氧合酶(HPPD);或來自磺醯基脲類、嘉磷塞(glyphosate)、固殺草(glufosinate)或苯甲醯基異唑類之除草劑、及類似活性物質。 The compounds according to the invention are preferably used in transgenic crops which are resistant to growth regulators (e.g., dicamba); or herbicides which inhibit plant essential enzymes (e.g., acetamidine lactide) Synthetase (ALS), EPSP synthase, branamine synthase (GS) or hydroxyphenylpyruvate dioxygenase (HPPD); or from sulfonyl ureas, glyphosate, geranium (glufosinate) or benzamidine Herbicide herbicides, and similar active substances.

當根據本發明活性物質用於轉殖基因作物時,除了可在其他作物中觀察到其對有害植物之效應外,亦經常可觀察到施用在特定轉殖基因作物時之特定效應,例如:經修改或特異化之擴大雜草控制範圍、修改可採用之施用率、與除草劑抗性轉殖基因作物之良好可組合性及對轉殖基因作物生長與產量之效應。 When the active substance according to the invention is used for the transfer of genetic crops, in addition to its effect on harmful plants, which can be observed in other crops, specific effects when applied to a particular transgenic crop are often observed, for example: Modification or specificization of expanded weed control, modified application rates, good combinability with herbicide-resistant transgenic crops, and effects on growth and yield of transgenic crops.

因此本發明亦有關一種以根據本發明化合物作為除草劑於控制轉殖基因作物中有害植物上之用途。 The invention therefore also relates to the use of a compound according to the invention as a herbicide for controlling harmful plants in a genetically modified crop.

根據本發明化合物可呈可濕性粉劑、可乳化濃縮劑、噴 灑液、塵粉劑或粒劑等型式用於習用製劑中。因此本發明亦有關包含根據本發明化合物之除草劑及植物生長調節劑。 The compound according to the invention may be in the form of a wettable powder, an emulsifiable concentrate, a spray Sprinkles, dust powders or granules are used in conventional preparations. The invention therefore also relates to herbicides and plant growth regulators comprising a compound according to the invention.

根據本發明化合物可依各種不同方式調配,端賴現行之生物與/或生理-化學參數而定。可能之調配物實例為:可濕性粉劑(WP)、水溶性粉劑(SP)、水溶性濃縮劑、可乳化濃縮劑(EC)、乳液(EW)(如:水包油及油包水性乳液)、噴灑液、水懸劑(SC)、油性或水性分散液、油混溶性溶液、膠囊懸浮液(CS)、塵粉劑(DP)、拌種產品、撒播用粒劑及土壤用粒劑、呈微粒型式之粒劑(GR)、噴灑粒劑、包衣粒劑及吸附粒劑、水分散性粒劑(WG)、水溶性粒劑(SG)、ULV調配物、微膠囊及蠟類。 The compounds according to the invention may be formulated in a variety of different ways depending on the current biological and/or physio-chemical parameters. Examples of possible formulations are: wettable powders (WP), water soluble powders (SP), water soluble concentrates, emulsifiable concentrates (EC), emulsions (EW) (eg, oil-in-water and oil-in-water emulsions). ), spray liquid, aqueous suspension (SC), oily or aqueous dispersion, oil miscible solution, capsule suspension (CS), dust powder (DP), seed dressing products, granules for spreading, and granules for soil, Particulate granules (GR), spray granules, coated granules and adsorbent granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes.

此等個別調配物型式係原則上已知者且說明於例如:Winnacker-Küchler之"Chemische Technologie"[化學技術],第7冊,C.Hanser Verlag Munich,第4版,1986;Wade van Valkenburg之"農藥調配物(Pesticide Formulations)",Marcel Dekker,N.Y.,1973;K.Martens之"噴霧乾燥法(Spray Drying)"手冊,第3版,1979,G.Goodwin Ltd.London。 These individual formulation types are known in principle and are described, for example, in "Chemische Technologie" by Winnacker-Küchler, Chemical Engineering, Vol. 7, C. Hanser Verlag Munich, 4th edition, 1986; Wade van Valkenburg "Pesticide Formulations", Marcel Dekker, NY, 1973; K. Martens, "Spray Drying" Handbook, 3rd edition, 1979, G. Goodwin Ltd. London.

所需之調配輔劑(如:惰性材料、表面活性劑、溶劑及其他添加劑)亦係已知者且說明於例如:Watkins之"殺昆蟲塵粉劑稀釋劑與載劑手冊(Handbook of Insecticide Dust Diluents and Carriers)",第2版,Darland Books,Caldwell N.J.,H.v.Olphen之"黏土膠體化學入門(Introduction to Clay Colloid Chemistry)";第2版,J.Wiley & Sons,N.Y.;C.Marsden之"溶劑指南(Solvents Guide)";第2版,Interscience,N.Y.1963;McCutcheon之"清潔劑與乳化劑年報(Detergents and Emulsifiers Annual)",MC Publ.Corp.,Ridgewood N.J.;Sisley 及Wood之"表面活性劑大全(Encyclopedia of Surface Active Agents)",Chem.Publ.Co.Inc.,N.Y.1964;Schönfeldt之"Grenzflächenaktive Athylenoxidaddukte"[環氧乙烷加合物表面活性劑],Wiss.Verlagsgesell.,Stuttgart 1976;Winnacker-Küchler之"Chemische Technologie"[化學技術],第7冊,C.Hanser Verlag Munich,第4版,1986。 The required adjuvants (eg, inert materials, surfactants, solvents, and other additives) are also known and described, for example, in Watkins' Handbook of Insecticide Dust Diluents. And Carriers)", 2nd Edition, Darland Books, Caldwell NJ, HvOlphen, "Introduction to Clay Colloid Chemistry"; 2nd Edition, J. Wiley & Sons, NY; C. Marsden" Solvent Guide (Solvents Guide); 2nd Edition, Interscience, NY 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ; Sisley And Wood's "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., NY 1964; Schönfeldt's "Grenzflächenaktive Athylenoxidaddukte" [Ethylene Oxide Adduct Surfactant], Wiss. Verlagsgesell., Stuttgart 1976; Winnacker-Küchler, "Chemische Technologie" [Chemical Technology], Vol. 7, C. Hanser Verlag Munich, 4th edition, 1986.

依據此等調配物,亦可能與其他農藥活性物質製成組合,如,例如:殺昆蟲劑、殺蜱蟎劑、除草劑、殺真菌劑及安全劑、肥料及/或生長調節劑,例如:呈現成混合物或大槽混合物。合適安全劑為例如:吡唑解草酯(mefenpyr-diethyl)、環丙磺醯胺(cyprosulfamide)、雙苯唑酸(isoxadifen-ethyl)、毒喹(cloquintocet-mexyl)及二氯丙烯胺(dichlormid)。 Depending on the formulation, it may also be combined with other pesticidally active substances such as, for example, insecticides, acaricides, herbicides, fungicides and safeners, fertilizers and/or growth regulators, for example: Presented as a mixture or a large tank mixture. Suitable safeners are, for example, mefenpyr-diethyl, cyprosulfamide, diphenyl Isoxadifen-ethyl, cloquintocet-mexyl and dichlormid.

可濕性粉劑為可均勻分散在水中之製劑,其中除了活性物質外,亦包含離子性與/或非離子性表面活性劑(濕化劑、分散劑),例如:除了稀釋劑或惰性物質外,尚包含聚氧乙基化烷基酚類、聚氧乙基化脂肪醇類、聚氧乙基化脂肪胺類、脂肪醇聚二醇醚硫酸酯類、烷磺酸酯類、烷基苯楎酸酯類、木質素磺酸鈉、2,2'-二萘基甲烷-6,6'-二磺酸鈉、二丁基萘磺酸鈉或油醯基甲基牛磺酸鈉。為了製備可濕性粉劑,取除草活性物質例如:於習知設備(如:錘磨機、碗磨機及氣壓噴射研磨機)中均勻細磨,並與調配輔劑同時或依序混合。 The wettable powder is a preparation which can be uniformly dispersed in water, and contains, in addition to the active material, an ionic and/or nonionic surfactant (wetting agent, dispersing agent), for example, in addition to a diluent or an inert substance. Also, polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenes A phthalate, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate or sodium decylmethyltaurate. In order to prepare a wettable powder, the herbicidal active substance is taken, for example, uniformly finely ground in a conventional apparatus (for example, a hammer mill, a bowl mill, and a pneumatic jet mill), and mixed with the compounding agent simultaneously or sequentially.

可乳化濃縮劑之製法為取活性物質溶於溶劑中,例如:丁醇、環己酮、二甲基甲醯胺、二甲苯或高沸點芳香系或烴類或在有機溶劑中添加一或多種離子性與/或非離子性表面活性劑(乳化劑)之混合物。可使用之乳化劑實例為:烷芳基磺酸鈣(如:十二烷基苯磺酸鈣)或非離子性乳化劑(如:脂肪 酸聚二醇酯類、烷芳基聚二醇醚類、脂肪醇聚二醇醚類、氧化丙烯/環氧乙烷縮合物、烷基聚醚類、山梨糖醇酐酯類(如,例如:山梨糖醇酐脂肪酸酯類)或聚氧乙烯山梨糖醇酐酯類(如,例如:聚氧乙烯山梨糖醇酐脂肪酸酯類)。 The emulsifiable concentrate is prepared by dissolving the active substance in a solvent, such as butanol, cyclohexanone, dimethylformamide, xylene or a high-boiling aromatic or hydrocarbon or adding one or more organic solvents. A mixture of ionic and/or nonionic surfactants (emulsifiers). Examples of emulsifiers that can be used are: calcium alkaryl sulfonates (eg calcium dodecylbenzene sulfonate) or nonionic emulsifiers (eg fats) Acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide/ethylene oxide condensates, alkyl polyethers, sorbitan esters (eg, for example : sorbitan fatty acid esters) or polyoxyethylene sorbitan esters (for example, polyoxyethylene sorbitan fatty acid esters).

塵粉劑製法係由活性物質與細碎固體材料,如,例如:滑石、礦物黏土(如:高嶺土、皂土與葉蠟石)、或矽藻土混合。 The dust powder preparation method is a mixture of an active material and a finely divided solid material such as, for example, talc, mineral clay (e.g., kaolin, bentonite and pyrophyllite), or diatomaceous earth.

水懸劑可為水性或油性。其可例如:利用自商品取得之球磨機,若適當時添加上列表面活性劑(例如:說明於其他調配物型態中者),進行濕磨法製得。 The aqueous suspension can be aqueous or oily. For example, it can be obtained by a wet milling method using a ball mill obtained from a product, and if necessary, adding a surfactant on the list (for example, as described in other formulation types).

乳液,例如:水包油性乳液(EW)之製法可例如:利用攪拌器、膠體研磨機及/或靜態混合器,使用水性有機溶劑,若適當時添加上列表面活性劑(例如:說明於其他調配物型態中者)。 The emulsion, for example, an oil-in-water emulsion (EW) can be produced, for example, by using a stirrer, a colloid mill and/or a static mixer, using an aqueous organic solvent, and adding a surfactant on the list if appropriate (for example: In the formulation type).

粒劑製法可由活性物質噴灑在吸附性粒狀惰性材料上,或藉助於黏著劑(例如:聚乙烯醇、聚丙烯酸鈉或礦物油類),將活性物質濃縮劑塗覆在載劑(如:砂、高嶺土或粒狀惰性材料)表面上。合適之活性物質亦可依習知之肥料顆粒製法(若需要時,可與肥料形成混合物)製成顆粒。 The granule preparation method may be sprayed on the adsorbent granular inert material by the active material, or the active material concentrate may be coated on the carrier by means of an adhesive (for example, polyvinyl alcohol, sodium polyacrylate or mineral oil) (for example: Sand, kaolin or granular inert material) on the surface. Suitable active materials can also be granulated according to conventional fertilizer granulation methods (if desired, with fertilizers).

水分散性粒劑通常採用習知方法製造,如:噴霧乾燥法、流化床製粒法、盤式製粒法、與高速攪拌器混合使用、及在不使用固態惰性材料下進行擠壓法。 Water-dispersible granules are usually produced by conventional methods such as spray drying, fluidized bed granulation, pan granulation, mixing with a high speed agitator, and extrusion without the use of solid inert materials. .

盤式粒劑、流化床粒劑、擠壓粒劑與噴霧乾燥粒劑之製法可參見例如:"噴霧乾燥法手冊(Spray-Drying Handbook)",第3版,1979,G.Goodwin Ltd.,London;J.E.Browning之"凝集法(Agglomeration)",Chemical and Engineering 1967, 第147頁以後;"派氏化學工程手冊(Perry's Chemical Engineer's Handbook)",第5版,McGraw-Hill,New York 1973,p.8-57中說明之方法。 For the preparation of disc granules, fluidized bed granules, extruded granules and spray-dried granules, see, for example, "Spray-Drying Handbook", 3rd edition, 1979, G. Goodwin Ltd. , London; JEBrowning's "Agglomeration", Chemical and Engineering 1967, After the 147th page; "Perry's Chemical Engineer's Handbook", 5th edition, McGraw-Hill, New York 1973, p. 8-57.

有關作物保護產品之調配物之進一步詳細說明可參見例如:G.C.Klingman之"雜草控制學(Weed Control as a Science)",John Wiley and Sons,Inc.,New York,1961,第81-96頁及J.D.Freyer、S.A.Evans之"雜草控制手冊(Weed Control Handbook)",第5版,Blackwell Scientific Publications,Oxford,1968,第101-103頁。 Further details on formulations of crop protection products can be found, for example, in Gecklingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pp. 81-96. And J. Freyer, SAEvans, "Weed Control Handbook", 5th ed., Blackwell Scientific Publications, Oxford, 1968, pp. 101-103.

通常,農化製劑包含0.1至99%重量比,特定言之0.1至95%重量比之根據本發明化合物。可濕性粉劑中,活性物質濃度為例如:約10至90%重量比,其餘由習知調配物組成份補足100%重量比。可乳化濃縮劑例子中,活性物質濃度可佔約1至90,較佳佔5至80%重量比。塵粉劑型之調配物可包含1至30%重量比之活性物質,大多數例子中較佳包含5至20%重量比活性物質,及噴灑液包含約0.05至80,較佳2至50%重量比之活性物質。水分散性粒劑例子中,活性物質含量係部份依活性化合物呈液態或固態而定,且依所採用之製粒輔劑、填料,等等而定。水分散性粒劑之例子中,例如:活性物質含量為1至95%重量比之間,較佳為10至80%重量比之間。 In general, the agrochemical preparation comprises from 0.1 to 99% by weight, in particular from 0.1 to 95% by weight, of the compound according to the invention. In the wettable powder, the active substance concentration is, for example, about 10 to 90% by weight, and the balance is made up to 100% by weight from the conventional formulation. In the case of an emulsifiable concentrate, the active material concentration may range from about 1 to 90, preferably from 5 to 80% by weight. The dust powder formulation may comprise from 1 to 30% by weight of active material, most preferably from 5 to 20% by weight of active material, and the spray liquid comprises from about 0.05 to 80, preferably from 2 to 50% by weight. Compared to active substances. In the case of water-dispersible granules, the active substance content depends in part on the active compound in liquid or solid form, and depends on the granulation aid, filler, and the like employed. In the case of the water-dispersible granules, for example, the active material content is between 1 and 95% by weight, preferably between 10 and 80% by weight.

此外,上述活性物質調配物若適當時,可包含各例中常用之輔劑,如:黏著劑、濕化劑、分散劑、乳化劑、滲透劑、防腐劑、防凍劑、溶劑、填料、載劑、著色劑、消泡劑、蒸發抑制劑、及pH與黏度調節劑。 In addition, the above active substance formulation may include auxiliary agents commonly used in each case, such as: an adhesive, a humidifying agent, a dispersing agent, an emulsifier, a penetrating agent, a preservative, an antifreeze, a solvent, a filler, and the like. Agents, colorants, defoamers, evaporation inhibitors, and pH and viscosity modifiers.

依據此等調配物,其亦可與其他農藥活性物質(如,例 如:殺昆蟲劑、殺蜱蟎劑、除草劑、殺真菌劑),及與安全劑、肥料及/或生長調節劑製成組合物,例如:現成可用混合物或大槽混合物型式。 According to these formulations, it can also be combined with other pesticide active substances (eg, For example: insecticides, acaricides, herbicides, fungicides, and compositions with safeners, fertilizers and/or growth regulators, for example, ready-to-use mixtures or large tank mixtures.

可與根據本發明化合物組合成混合調配物或大槽混合物之活性物質為例如:可以抑制例如:乙醯乳酸合成酶、乙醯基-CoA羧化酶、纖維素合成酶、烯醇丙酮酸莽草酸-3-磷酸酯合成酶、麩醯胺合成酶、對羥基苯基丙酮酸二氧合酶、八氫番茄紅素脫氫酶(phytoen desaturase)、光系統I、光系統II、原卟啉原氧化酶之已知活性物質說明於例如:Weed Research 26(1986)441-445或"農藥手冊(The Pesticide Manual)",第14版,The British Crop Protection Council and the Royal Soc.of Chemistry,2003及其中摘錄之文獻。可與根據本發明化合物組合之已知除草劑或植物生長調節劑為例如:下列活性物質(根據國際標準化組織(International Organization for Standardization(ISO))之俗名或以化學名稱命名之化合物,若適當時並配合出示代碼),且總是包括所有施用型式,如:酸類、鹽類、酯類及異構物,如:立體異構物及光學異構物。 The active substance which can be combined with the compound according to the invention into a mixed formulation or a large tank mixture is, for example, inhibited, for example, acetamidine lactate synthase, acetyl-CoA carboxylase, cellulose synthase, quinone enolate Oxalic acid-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoen desaturase, photosystem I, photosystem II, protoporphyrin Known active substances of pro-oxidase are described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 14th edition, The British Crop Protection Council and the Royal Soc. of Chemistry, 2003. And the literature extracted from it. Known herbicides or plant growth regulators which may be combined with the compounds according to the invention are, for example, the following active substances (according to the common name of the International Organization for Standardization (ISO) or a chemically named compound, if appropriate And cooperate with the production of the code), and always include all application forms, such as: acids, salts, esters and isomers, such as: stereoisomers and optical isomers.

使用呈商品型態之調配物時,若適當時可依習知方式稀釋,例如:可濕性粉劑、可乳化濃縮劑、分散劑及水分散性粒劑等例係使用水稀釋。呈塵粉劑、土壤粒劑、撒播粒劑及噴灑液型式之製劑通常在施用前不再使用其他惰性物質稀釋。 When a formulation in a commercial form is used, it may be diluted in a conventional manner as appropriate, for example, a wettable powder, an emulsifiable concentrate, a dispersant, and a water-dispersible granule are diluted with water. Formulations in the form of dusting powders, soil granules, granules and sprays are usually not diluted with other inert materials prior to application.

所需之式(I)化合物施用率會隨外部條件變化,如:溫度、濕度、所採用除草劑性質,等等。其可在很大限制範圍內變化,例如:0.001至1.0 kg/ha及更高之活性物質之間,但較佳在0.005至750 g/ha之間。 The rate of application of the compound of formula (I) required will vary with external conditions such as temperature, humidity, herbicidal properties employed, and the like. It can vary within a wide range of limitations, for example between 0.001 and 1.0 kg/ha and higher, but preferably between 0.005 and 750 g/ha.

下列實例說明本發明。 The following examples illustrate the invention. A.化學實例 A. Chemistry example 5-羥基-1,3-二甲基-4-[3-(N-氰基-S-甲基磺醯亞胺基)-2-甲氧基-4-(三氟甲基)苯甲醯基]吡唑(表中實例編號4-160)之合成法 5-hydroxy-1,3-dimethyl-4-[3-(N-cyano-S-methylsulfonimido)-2-methoxy-4-(trifluoromethyl)benzene Synthesis of thiol]pyrazole (example number 4-160 in the table) 步驟1:3-(N-氰基-S-甲基磺醯亞胺基)-2-甲氧基-4-(三氟甲基)苯甲酸(表中實例編號15-28)之合成法 Step 1: Synthesis of 3-(N-cyano-S-methylsulfonimido)-2-methoxy-4-(trifluoromethyl)benzoic acid (Example No. 15-28 in the table)

取3.71 g(33.1 mmol)第三丁醇鉀加至含4.00 g(15.0 mmol)2-甲氧基-3-(甲基硫烷基)-4-(三氟甲基)苯甲酸之250 ml甲醇中。攪拌混合物10分鐘,然後依序添加1.07 g(25.5 mmol)氰醯胺及4.81 g(27.0 mmol)N-溴琥珀醯亞胺。反應內容物於室溫下攪拌2小時。然後於旋轉蒸發器上蒸發排除溶劑,殘質溶於各120 ml之乙腈與水之混合物中。添加7.21 g(45.1 mmol)過錳酸鈉單水合物,於室溫下攪拌混合物一週。在這週期間,在一天後及再一天後分別添加3.6 g(22.5 mmol)過錳酸鈉單水合物。操作時,添加10%重量比之硫酸氫鈉溶液。於旋轉蒸發器上,在最高30℃之溫度下,實質上排除溶劑。殘質於冰浴中冷卻後,添加1M鹽酸酸化。使用冰冷之二氯甲烷萃取3次。於旋轉蒸發器上排除合併之有機相中之溶劑,殘質經層析法純化,產生1.30 g產物,純度80%重量比。 3.71 g (33.1 mmol) of potassium t-butoxide was added to 250 ml containing 4.00 g (15.0 mmol) of 2-methoxy-3-(methylsulfanyl)-4-(trifluoromethyl)benzoic acid. In methanol. The mixture was stirred for 10 minutes, then 1.07 g (25.5 mmol) of cyanopyramine and 4.81 g (27.0 mmol) of N-bromosuccinimide were added sequentially. The reaction contents were stirred at room temperature for 2 hours. The solvent was then evaporated on a rotary evaporator and the residue was dissolved in a mixture of 120 ml of acetonitrile and water. 7.21 g (45.1 mmol) of sodium permanganate monohydrate was added, and the mixture was stirred at room temperature for one week. During this period, 3.6 g (22.5 mmol) of sodium permanganate monohydrate was added after one day and one day later. In operation, a 10% by weight sodium hydrogen sulfate solution was added. On a rotary evaporator, the solvent is substantially excluded at temperatures up to 30 °C. After the residue was cooled in an ice bath, it was acidified with 1 M hydrochloric acid. It was extracted 3 times with ice-cold dichloromethane. The solvent in the combined organic phase was removed on a rotary evaporator and the residue was purified by chromatography to yield 1.30 g.

步驟2:5-羥基-1,3-二甲基-4-[3-(N-氰基-S-甲基磺醯亞胺基)-2-甲氧基-4-(三氟甲基)苯甲醯基]吡唑之合成法 Step 2: 5-Hydroxy-1,3-dimethyl-4-[3-(N-cyano-S-methylsulfonimido)-2-methoxy-4-(trifluoromethyl) Synthesis of benzhydryl]pyrazole

先添加165 mg(75%重量比;0.384 mmol)3-(N-氰基-S-甲基磺醯 亞胺基)-2-甲氧基-4-(三氟甲基)苯甲酸及68.9 mg(0.614 mmol)5-羥基-1,3-二甲基吡唑至20 ml二氯甲烷中,添加128 mg(0.666 mmol)1-(3-二甲基胺基丙基)-3-乙基碳化二亞胺鹽酸鹽。於室溫下攪拌混合物16小時,操作時,使用1M鹽酸洗滌。分相後,取有機相脫水,過濾及於旋轉蒸發器上排除溶劑。殘質經層析法純化,所得中間物再溶於15 ml乙腈中。添加104 mg(1.02 mmol)三乙基胺、8滴三甲基氰化物及藥匙尖端量之氰化鉀。於室溫下攪拌混合物16小時,操作時,排除溶劑。殘質溶於二氯甲烷,使用3 ml 1M鹽酸洗滌。分相後,排除有機相之溶劑,殘質經層析法純化,產生31.3 mg 5-羥基-1,3-二甲基-4-[3-(N-氰基-S-甲基磺醯亞胺基)-2-甲氧基-4-(三氟甲基)苯甲醯基]吡唑,純度85%重量比。下表所列實例係類似上述方法製備或類似上述方法取得。以此等化合物極特別佳。所使用之縮寫如下:Et=乙基 Me=甲基 n-Pr=正丙基 i-Pr=異丙基 c-Pr=環丙基 Ph=苯基 First add 165 mg (75% by weight; 0.384 mmol) of 3-(N-cyano-S-methylsulfonate) Imino)-2-methoxy-4-(trifluoromethyl)benzoic acid and 68.9 mg (0.614 mmol) of 5-hydroxy-1,3-dimethylpyrazole to 20 ml of dichloromethane, added 128 mg (0.666 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride. The mixture was stirred at room temperature for 16 hours, and was washed with 1M hydrochloric acid. After phase separation, the organic phase was dehydrated, filtered and the solvent was removed on a rotary evaporator. The residue was purified by chromatography and the obtained intermediate was dissolved in 15 ml of acetonitrile. 104 mg (1.02 mmol) of triethylamine, 8 drops of trimethyl cyanide and a tip of potassium cyanide were added. The mixture was stirred at room temperature for 16 hours, and the solvent was removed during the operation. The residue was dissolved in dichloromethane and washed with 3 mL 1M hydrochloric acid. After phase separation, the solvent of the organic phase is excluded, and the residue is purified by chromatography to give 31.3 mg of 5-hydroxy-1,3-dimethyl-4-[3-(N-cyano-S-methylsulfonate). Imino)-2-methoxy-4-(trifluoromethyl)benzylidene]pyrazole, purity 85% by weight. The examples listed in the table below were prepared analogously to the methods described above or similar to the methods described above. Such compounds are extremely preferred. The abbreviations used are as follows: Et = ethyl Me = methyl n-Pr = n-propyl i-Pr = isopropyl c-Pr = cyclopropyl Ph = phenyl

表3a:根據本發明式(I)化合物,其中Q為Q3,Ri為乙基,及Rh、Rk與W分別為氫,t=1,其他基團均如表中所示之定義 Table 3a: A compound of formula (I) according to the invention wherein Q is Q3, R i is ethyl, and R h , R k and W are respectively hydrogen, t=1, and other groups are as defined in the table

表6:根據本發明式(I)化合物,其中Q為Q5,W為氫,t=1,其他基團均如表中所示之定義 Table 6: Compounds of formula (I) according to the invention, wherein Q is Q5, W is hydrogen, t=1, and other groups are as defined in the table

表9:根據本發明式(I)化合物,其中Q為Q2,Ra為羥基,Rb、Rf與W分別為氫,A為CH2CH2,Y為CH2,t=0,其他基團均如表中所示之定義 Table 9: Compounds of formula (I) according to the invention wherein Q is Q2, R a is hydroxy, R b , R f and W are respectively hydrogen, A is CH 2 CH 2 , Y is CH 2 , t=0, others The groups are as defined in the table

表11:根據本發明式(I)化合物,其中Q為Q3,Ri及Rk分別為甲基,Rh與W分別為氫,t=0,其他基團均如表中所示之定義 Table 11: Compounds of formula (I) according to the invention, wherein Q is Q3, R i and R k are each methyl, R h and W are respectively hydrogen, t=0, and other groups are as defined in the table

表14:根據本發明式(I)化合物,其係呈鈉鹽型,其中Q為Q3,Ri為甲基,Rk與W分別為氫,t=0,其他基團均如表中所示之定義 Table 14: A compound of formula (I) according to the invention, which is in the form of a sodium salt, wherein Q is Q3, R i is methyl, R k and W are respectively hydrogen, t=0, and other groups are as shown in the table. Definition of indication

表17:根據本發明式(II)化合物,其中Q*為氯及R'為氰基,t為1,其他基團均如表中所示之定義 Table 17: Compounds of formula (II) according to the invention wherein Q* is chloro and R' is cyano, t is 1, and other groups are as defined in the table

B.調配物實例 B. Formulation examples

a)塵粉劑之製法為混合10份重量比之式(I)化合物與/或其鹽類及90份重量比之滑石(作為惰性物質),並於錘磨機中研磨混合物。 a) Dust powder is prepared by mixing 10 parts by weight of the compound of the formula (I) and/or its salts and 90 parts by weight of talc (as an inert substance), and grinding the mixture in a hammer mill.

b)容易分散在水中之可濕性粉劑之製法為混合25份重量比之式(I)化合物與/或其鹽類、64份重量比之含高嶺土之石英(作為惰性物質)、10份重量比之木質素磺酸鉀及1份重量比油醯基甲基牛磺酸鈉(作為濕化劑與分散劑),並於棒式圓盤磨粉機(pinned-disk mill)中研磨混合物。 b) The wettable powder which is easily dispersed in water is prepared by mixing 25 parts by weight of the compound of the formula (I) and/or its salt, 64 parts by weight of quartz containing kaolin (as an inert substance), and 10 parts by weight. The mixture was milled in a pinned-disk mill than potassium lignin sulfonate and 1 part by weight of sodium oleylmethyltaurate (as a wetting agent and dispersant).

c)容易分散在水中之分散濃縮劑之製法為混合20份重量比之式(I)化合物與/或其鹽類與6份重量比之烷基酚聚二醇醚(®Triton X 207)、3份重量比之異十三烷醇聚二醇醚(8 EO)及71份重量比之石蠟礦物油(沸點範圍為例如:約255至277℃以上),並於碗磨機中研磨混合物至低於5微米之細度。 c) a dispersing concentrate which is easily dispersed in water is prepared by mixing 20 parts by weight of the compound of the formula (I) and/or its salt with 6 parts by weight of an alkylphenol polyglycol ether (® Triton X 207), 3 parts by weight of isotridecyl alcohol polyglycol ether (8 EO) and 71 parts by weight of paraffinic mineral oil (boiling range is, for example, about 255 to 277 ° C or higher), and the mixture is ground in a bowl mill to Fineness below 5 microns.

d)可乳化濃縮劑係由15份重量比之式(I)化合物與/或其鹽類、75份重量比之環己酮(作為溶劑)及10份重量比之乙氧基化壬基酚(作為乳化劑)製得。 d) an emulsifiable concentrate comprising 15 parts by weight of a compound of the formula (I) and/or a salt thereof, 75 parts by weight of cyclohexanone (as a solvent) and 10 parts by weight of an ethoxylated nonylphenol (made as an emulsifier).

e)水分散性粒劑之製法為混合75份重量比之式(I)化合物與/或其鹽類,10份重量比之木質素磺酸鈣,5份重量比之月桂基硫酸鈉,3份重量比之聚乙烯基醇,及7份重量比之高嶺土,於棒式圓盤磨粉機中研磨混合物,粉末於流化床上使用水(作為製粒液體)噴灑製成粒劑。 e) The water-dispersible granule is prepared by mixing 75 parts by weight of the compound of the formula (I) and/or its salt, 10 parts by weight of calcium lignin sulfonate, and 5 parts by weight of sodium lauryl sulfate, 3 The mixture was ground in a bar disc mill with a weight ratio of polyvinyl alcohol and 7 parts by weight of kaolin. The powder was sprayed on a fluidized bed using water (as a granulating liquid) to form a granule.

f)水分散性粒劑之製法亦可於膠體研磨機中均質化及預先研磨:25份重量比之式(I)化合物與/或其鹽類,5份重量比之2,2'-二萘基甲烷-6,6'-二磺酸鈉,2份重量比之油醯基甲基牛磺酸鈉,1份重量比之聚乙烯基醇,17份重量比之碳酸鈣,及50份重量比之水,隨後於珠磨機中研磨混合物,所得懸浮液於噴霧塔中,利用單物質噴嘴進行噴霧乾燥。 f) The method for preparing the water-dispersible granules can also be homogenized and pre-ground in a colloid mill: 25 parts by weight of the compound of the formula (I) and/or its salts, 5 parts by weight of 2, 2'-two Naphthylmethane-6,6'-disulfonic acid sodium, 2 parts by weight of sodium sulphate methyl taurate, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate, and 50 parts by weight The weight ratio of water was followed by grinding the mixture in a bead mill and the resulting suspension was spray dried in a spray tower using a single substance nozzle.

C.生物實例 C. Biological examples 1.對抗有害植物之出土前除草效應 1. Anti-herbicide effect before the emergence of harmful plants

取單子葉或雙子葉雜草或作物之種子置入木質纖維盆之砂質壤土中,並覆蓋土壤。然後取調配成可濕性粉劑(WP)或乳液濃縮劑(EC)型式之根據本發明化合物,添加0.2%濕化劑,以水性懸浮液或乳液型式,依600至800 l/ha(換算後)之水施用率施用至土壤表面。處理後,盆栽置於溫室內,保持在適合試驗植物之良好生長條件下。經過3週實驗期後,與未處理之對照組比較,目視評分試驗植物之傷害(除草活性百分比(%):100%活性=植物已死亡,0%活性=如同對照組植物)。此時例如:編號3-160及4-160之化合物在320 g/ha之施用率下,分別對苘麻(Abutilon theophrasti)及莧(Amaranthus retroflexus)顯示至少80%之活性強度。化合物編號2-160及10a-160在320 g/ha之施用率下,分別對卷莖蓼(Polygonum convolvulus)及繁縷(Stellaria media)顯示至少80%活性強度。 Seeds of monocotyledonous or dicotyledonous weeds or crops are placed in sandy loam of wood fiber pots and covered with soil. Then, according to the compound of the present invention formulated into a wettable powder (WP) or emulsion concentrate (EC) type, 0.2% of the wetting agent is added, in an aqueous suspension or emulsion form, according to 600 to 800 l/ha (after conversion) The water application rate is applied to the soil surface. After treatment, the pots were placed in a greenhouse and maintained under good growth conditions suitable for the test plants. After a three-week experimental period, the visually scored plants were tested for damage (% herbicidal activity (%): 100% active = plant dead, 0% active = like control plants) compared to the untreated control group. At this time, for example, the compounds of No. 3-160 and 4-160 showed an activity intensity of at least 80% against ramie (Abutilon theophrasti) and 苋 (Amaranthus retroflexus) at an application rate of 320 g/ha, respectively. Compound Nos. 2-160 and 10a-160 showed at least 80% activity intensity against Polygonum convolvulus and Stellaria media at an application rate of 320 g/ha, respectively.

2.對抗有害植物之出土後除草效應 2. Anti-herbic effect after the emergence of harmful plants

取單子葉或雙子葉雜草或作物之種子置入木質纖維盆之砂質壤土中,並覆蓋土壤,置於溫室中,在良好生長條件下生長。播種2至3週後,於第一葉階段處理植物。然後取調配成可濕性粉劑(WP)或乳液濃縮劑(EC)型式之根據本發明化合物,添加0.2%濕化劑,以水性懸浮液或乳液型式,依600至800 l/ha(換算後)之水施用率施用至綠色植株上。試驗植物留在溫室內最佳生長條件下約3週後,與未處理之對照組比較,目視評分製劑之活性(除草活性百分比(%):100%活性=植物已死亡,0%活性=如同對照組植物)。此時例如:編號2-160、3-160、4-160及10a-160之化合物在80 g/ha之施用率下,分別對苘麻(Abutilon theophrasti)及稗(Echinochloa crus galli)顯示至少80%之活性強度。 Seeds of monocotyledonous or dicotyledonous weeds or crops are placed in sandy loam of wood fiber pots, covered with soil, placed in a greenhouse, and grown under good growing conditions. After 2 to 3 weeks of sowing, the plants are treated at the first leaf stage. Then, according to the compound of the present invention formulated into a wettable powder (WP) or emulsion concentrate (EC) type, 0.2% of the wetting agent is added, in an aqueous suspension or emulsion form, according to 600 to 800 l/ha (after conversion) The water application rate is applied to the green plants. The test plants were left in the greenhouse for about 3 weeks under optimal growth conditions, and the activity of the visually-scoring preparation was compared with the untreated control group (% herbicidal activity (%): 100% activity = plant died, 0% activity = like Control plant). At this time, for example, the compounds of the numbers 2-160, 3-160, 4-160, and 10a-160 exhibit at least 80 for Abutilon theophrasti and Echinochloa crus galli at an application rate of 80 g/ha, respectively. % of activity intensity.

Claims (15)

一種式(I)亞磺醯亞胺基-及磺醯亞胺基苯甲醯基衍生物, 或其鹽,其中Q 為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基、R6S、R7(R8)N,Rb、Rc、Rf及Rg 分別獨立為氫或(C1-C4)-烷基,Rd、Re 分別獨立為氫或(C1-C4)-烷基或與其所附接之碳原子共同形成羰基,Rh 為氫、(C1-C6)-烷基磺醯基、(C1-C4)-烷氧基-(C1-C6)-烷基磺醯基、苯基磺醯基、硫苯基-2-磺醯基、苯甲醯基、苯甲醯基-(C1-C6)-烷基、苯甲基,其中最後述及之5個基團可需要經鹵素、(C1-C4)-烷基或(C1-C4)-烷氧基單取代或多取代,Ri 為(C1-C4)-烷基,Rk 為氫、(C1-C4)-烷基、(C3-C7)-環烷基,A及Y 分別獨立為氧、S(O)n、N(R3)、羰基或(C1-C4)-伸烷基,其係 經n個R9基團取代並插入n個選自下列各物所組成群中之元素:氧、S(O)n、N(R3)及羰基,X 為硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烯基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、(C3-C6)-環烯基-(C1-C6)-烷基、鹵-(C3-C6)-環烯基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、(R1)2N(R1)N(O)C、R1(O)C(R1)N(O)C、R2O(O)C(R1)N(O)C、(R1)2N(O)C(R1)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、(R1)2N(R1)N(O)C-(C1-C6)-烷基、R1(O)C(R1)N(O)C-(C1-C6)-烷基、R2O(O)C(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)C-(C1-C6)-烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、 R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,Z 為氫、硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烯基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、(C3-C6)-環烯基-(C1-C6)-烷基、鹵-(C3-C6)-環烯基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、(R1)2N(R1)N(O)C、R1(O)C(R1)N(O)C、R2O(O)C(R1)N(O)C、(R1)2N(O)C(R1)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、(R1)2N(R1)N(O)C-(C1-C6)-烷基、R1(O)C(R1)N(O)C-(C1-C6)-烷基、R2O(O)C(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)C-(C1-C6)- 烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,W 為氫、鹵素、硝基、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C7)-環烷基、鹵-(C3-C7)-環烷基、(C1-C6)-烷氧基、鹵-(C1-C6)-烷氧基、(C1-C6)-烷基-(O)nS-、(C1-C6)-鹵烷基-(O)nS-、(C1-C6)-烷氧基-(C1-C4)-烷基、(C1-C6)-烷氧基-(C1-C4)-鹵烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N、R1(O)C(R1)N或R2(O)2S(R1)N,R 為(C1-C6)-烷基、(C2-C6)-烯基或(C2-C6)-炔基,其分別經s個 選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1S(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1O(R1)N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1C(O)S、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S及(R5O)2(O)P,或為(C3-C6)-環烷基、(C3-C6)-環烯基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R1)-(C1-C6)-烷基、雜芳基-N(R1)-(C1-C6)-烷基、雜環基-N(R1)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基或雜環基-S(O)n-(C1-C6)-烷基,其各環狀部份基團經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、R1O(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1S(O)C、R1O、R1(O)CO、R2(O)2SO、R2O(O)CO、(R1)2N(O)CO、(R1)2N、R1O(R1)N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R1O(O)2S(R1)N、(R1)2N(O)2S(R1)N、R2(O)nS、R1C(O)S、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、(R5O)2(O)P及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R’ 為氫、硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、 (C3-C6)-烯基、鹵-(C3-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R2O(O)C、(R1)2N(O)C、R2S(O)C、(R1)2N(S)C、R1(R1O)N(O)C、R2(O)2S(R1)N(O)C、(R1)2N(O)2S(R1)N(O)C、R1O、(R1)2N、R2(O)nS、(R2)3Si-(C1-C6)-烷基-(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S、(R1)2N(O)C(R1)N(O)2S、R2(O)2S(R1)N(O)2S、(R5O)2(O)P、(R2)3Si、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、(R1O)(R1)N(O)C-(C1-C6)-烷基、R2(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O(O)2S(R1)N(O)C-(C1-C6)-烷基、(R1)2N(O)2S(R1)N(O)C-(C1-C6)-烷基、R1O-(C1-C6)-烷基、R1(O)CO-(C1-C6)-烷基、R2(O)2SO-(C1-C6)-烷基、R2O(O)CO-(C1-C6)-烷基、(R1)2N(O)CO-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R1O(O)2S(R1)N-(C1-C6)-烷基、(R1)2N(O)2S(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、R1(O)C(R1)N(O)2S-(C1-C6)-烷基、R2O(O)C(R1)N(O)2S-(C1-C6)-烷基、(R1)2N(O)C(R1)N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、(R2)3Si-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個苯基、雜芳基及雜環基之環狀部份基團經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基, R1 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R3)-(C1-C6)-烷基、雜芳基-N(R3)-(C1-C6)-烷基、雜環基-N(R3)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基、雜環基-S(O)n-(C1-C6)-烷基,其中最後述及之15個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS、R3O(O)2S、(R3)2N(O)2S及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R2 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、鹵-(C2-C6)-烯基、(C2-C6)-炔基、鹵-(C3-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烯基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基、苯基-N(R3)-(C1-C6)-烷基、雜芳基-N(R3)-(C1-C6)-烷基、雜環基-N(R3)-(C1-C6)-烷基、苯基-S(O)n-(C1-C6)-烷基、雜芳基-S(O)n-(C1-C6)-烷基、雜環基-S(O)n-(C1-C6)-烷基,其中最後述及之15個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R3O(O)C、 (R3)2N(O)C、R3O、(R3)2N、R4(O)nS、R3O(O)2S、(R3)2N(O)2S及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R3 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基或苯基,R4 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基或苯基,R5 為氫或(C1-C4)-烷基,R6 為(C1-C4)-烷基或為苯基,其係經m個選自下列各物所組成群中之基團取代:鹵素、硝基、氰基、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基及(C1-C4)-鹵烷氧基,R7 為氫、(C1-C4)-烷基或(C1-C4)-烷氧基,R8 為氫或(C1-C4)-烷基,或R7及R8與其所附接之氮原子共同形成5-或6-員飽和、部分飽和或不飽和環,其另外包含n個選自氮、氧及硫所組成群中之雜原子,且係經m個選自下列各物所組成群中之基團取代:鹵素、氰基、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基及(C1-C4)-鹵烷氧基,R9 為鹵素、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基、(C1-C4)-鹵烷氧基或(C1-C4)-烷氧基-(C1-C4)-烷基,m 為0、1、2、3、4或5,n 為0、1或2,s 為0、1、2或3,t 為0或1。 a sulfinimide group- and sulfonimidobenzamide derivative of the formula (I), Or a salt thereof, wherein Q is a group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, R 6 S, R 7 (R 8 ) N, R b , R c , R f and R g are each independently hydrogen or (C 1 -C 4 )-alkyl, and R d and R e are respectively Independently hydrogen or (C 1 -C 4 )-alkyl or a carbon atom attached thereto to form a carbonyl group, Rh is hydrogen, (C 1 -C 6 )-alkylsulfonyl, (C 1 -C 4 )-Alkoxy-(C 1 -C 6 )-alkylsulfonyl, phenylsulfonyl, thiophenyl-2-sulfonyl, benzhydryl, benzhydryl-(C 1 -C 6 )-alkyl, benzyl, wherein the last 5 groups may need to be monosubstituted by halogen, (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy Or polysubstituted, R i is (C 1 -C 4 )-alkyl, R k is hydrogen, (C 1 -C 4 )-alkyl, (C 3 -C 7 )-cycloalkyl, A and Y are respectively Independently of oxygen, S(O) n , N(R 3 ), carbonyl or (C 1 -C 4 )-alkylene, which is substituted by n R 9 groups and inserted into n selected from the following The elements in the group: oxygen, S(O) n , N(R 3 ) and carbonyl, X is nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halogen - (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6) - alkynyl, (C 3 -C 6) - Alkyl, halo - (C 3 -C 6) - cycloalkyl, (C 3 -C 6) - cycloalkenyl, halo - (C 3 -C 6) - cycloalkenyl, (C 3 -C 6) -cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cyclo Alkenyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkenyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=) C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, (R 1 ) 2 N(R 1 )N( O) C, R 1 (O) C(R 1 )N(O)C, R 2 O(O)C(R 1 )N(O)C, (R 1 ) 2 N(O)C(R 1 N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O 2 S(R 1 )N(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO , (R 1 ) 2 N, R 1 (O) C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S , R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 ) N(O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-(C 1 - C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, (R 1 O)(R 1 )N(O)C- (C 1 -C 6 )-alkyl, (R 1 ) 2 N(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N ( O) C-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N ( O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkane Base, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N(O) C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 (O)CO-(C 1 -C 6 )-alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 )-alkyl, (R 1 2 N(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-( C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N-( C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 - C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-(C 1 - C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, benzene , heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 ) - an alkyl group, wherein the last six groups are respectively substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 ) -alkyl, and wherein the heterocyclic group bears n pendant oxy groups, Z is hydrogen, nitro, halogen, cyano, thiocyaninyl, (C 1 -C 6 )-alkyl, halo-(C 1 - C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 - alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkenyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 ) - alkyl, (C 3 -C 6) - cycloalkenyl, - (C 1 -C 6) - alkyl Halo - (C 3 -C 6) - cycloalkenyl, - (C 1 -C 6) - alkyl, R 1 (O) C, R 1 (R 1 ON =) C, R 1 O (O) C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, (R 1 ) 2 N(R 1 )N(O)C, R 1 (O)C(R 1 ) N(O)C, R 2 O(O)C(R 1 )N(O)C, (R 1 ) 2 N(O)C(R 1 )N(O)C, R 2 (O) 2 S (R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO, (R 1 ) 2 N, R 1 (O)C (R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N ( O)C(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C -(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, (R 1 O)(R 1 )N(O)C-( C 1 -C 6 )-alkyl, (R 1 ) 2 N(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N(O C-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O C(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 ) N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 ( O) CO-(C 1 -C 6 )-alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 )- Alkyl, (R 1 ) 2 N(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C ( R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S( R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, phenyl, heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 - C 6) - alkyl, heterocyclyl - (C 1 -C 6) - alkyl, where the six last-mentioned S-th groups each consisting of each group were selected from the following group of substituents: nitro, halogen, cyano, thiocyanate acyl, (C 1 -C 6) - alkyl, halo - (C 1 - C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n a pendant oxy group, W is hydrogen, halogen, nitro, cyano, thiocyaninyl, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 - C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 7 )-cycloalkyl, halo-(C 3 -C 7 )-cycloalkyl, (C 1 -C 6 )-alkoxy, halo-(C 1 -C 6 )-alkoxy, (C 1 - C 6 )-alkyl-(O) n S-, (C 1 -C 6 )-haloalkyl-(O) n S-, (C 1 -C 6 )-alkoxy-(C 1 -C 4 )-alkyl, (C 1 -C 6 )-alkoxy-(C 1 -C 4 )-haloalkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O (O)C, (R 1 ) 2 N, R 1 (O)C(R 1 )N or R 2 (O) 2 S(R 1 )N, R is (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl or (C 2 -C 6 )-alkynyl, which are each composed of s selected from the following Group substitution in the group: nitro, halogen, cyano, thiocyaninyl, (C 3 -C 6 )-cycloalkyl, R 1 (O)C, R 1 (R 1 ON=) C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 S(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N(O)CO, (R 1 ) 2 N, R 1 O(R 1 )N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S(R 1 )N, R 2 (O) n S, R 1 C(O)S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N (O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S and (R 5 O) 2 (O)P, or (C 3 -C 6 )-cycloalkane , (C 3 -C 6 )-cycloalkenyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, Heterocyclyl, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )-alkane , heterocyclic-O-(C 1 -C 6 )-alkyl, phenyl-N(R 1 )-(C 1 -C 6 )-alkyl, heteroaryl-N(R 1 )-( C 1 -C 6) - alkyl, heterocyclyl -N (R 1) - (C 1 -C 6) - alkyl, phenyl, -S (O) n - (C 1 -C 6) - alkyl, heteroaryl group -S (O) n - (C 1 -C 6 )-alkyl or heterocyclyl-S(O) n -(C 1 -C 6 )-alkyl, each cyclic moiety of which is selected from the group consisting of the following: Group substitution: nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )- Cycloalkyl, R 1 (O) C, R 1 (R 1 ON=) C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 1 (R 1 O)N(O C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O(O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S( R 1 )N(O)C, R 1 S(O)C, R 1 O, R 1 (O)CO, R 2 (O) 2 SO, R 2 O(O)CO, (R 1 ) 2 N (O)CO, (R 1 ) 2 N, R 1 O(R 1 )N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O ( O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 1 O(O) 2 S(R 1 )N, (R 1 ) 2 N(O) 2 S (R 1 )N, R 2 (O) n S, R 1 C(O)S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, R 1 (O)C ( R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S, ( R 5 O) 2 (O) P , and R 1 O- (C 1 -C 6 ) - alkyl, and wherein the heterocyclyl group side with n, R 'is hydrogen, nitro, halo, cyano, (C 1 -C 6) - alkyl, halo - (C 1 -C 6) - alkyl, (C 3 -C 6) - alkenyl, halo - (C 3 -C 6) - alkenyl, (C 2- C 6 )-Alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3- C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O C, R 2 O(O)C, (R 1 ) 2 N(O)C, R 2 S(O)C, (R 1 ) 2 N(S)C, R 1 (R 1 O)N ( O) C, R 2 (O) 2 S(R 1 )N(O)C, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, (R 2 ) 3 Si-(C 1 -C 6 )-alkyl-(O) n S, R 1 O(O) 2 S, (R 1 ) 2 N (O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S, (R 1 ) 2 N(O) C(R 1 )N(O) 2 S, R 2 (O) 2 S(R 1 )N(O) 2 S, (R 5 O) 2 (O)P, (R 2 ) 3 Si, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 - C 6 )-alkyl, (R 1 O)(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N(O)C- (C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N(O)C-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, R 1 (O)CO-(C 1 -C 6 -alkyl, R 2 (O) 2 SO-(C 1 -C 6 )-alkyl, R 2 O(O)CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N ( O) CO-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 ) -alkyl, (R 1 ) 2 N(O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )- Alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, R 1 (O C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )- Alkyl, (R 1 ) 2 N(O)C(R 1 )N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 - C 6 )-alkyl, (R 2 ) 3 Si-(C 1 -C 6 )-alkyl, phenyl, heteroaryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, Heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )-alkyl, wherein the last 6 phenyl, heteroaryl and heterocyclic ring Part of the group is substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate , (C 1 -C 6) - alkyl, halo - (C 1 -C 6) - alkyl, (C 3 -C 6) - cycloalkyl, R 1 O (O) C , (R 1) 2 N(O)C, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O- (C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n pendant oxy groups, R 1 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkane , (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl- (C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkyl- O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, hetero Cyclo, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )-alkyl , heterocyclyl-O-(C 1 -C 6 )-alkyl, phenyl-N(R 3 )-(C 1 -C 6 )-alkyl, heteroaryl-N(R 3 )-(C 1- C 6 )-alkyl, heterocyclic-N(R 3 )-(C 1 -C 6 )-alkyl, phenyl-S(O) n -(C 1 -C 6 )-alkyl, Heteroaryl-S(O) n -(C 1 -C 6 )-alkyl, heterocyclyl-S(O) n -(C 1 -C 6 )-alkyl, wherein the last 15 groups are respectively s selected from the group consisting of the following Group substitution: nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-ring Alkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, (R 3 ) 2 N(O) 2 S and R 3 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group bears n pendant oxy groups and R 2 is (C 1 -C 6 )- Alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl , halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkane , (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, ring Alkyl-(C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl -(C 1 -C 6 )-alkyl, heterocyclic, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl group -O- (C 1 -C 6) - alkyl, heterocyclyl -O- (C 1 -C 6) - alkyl Phenyl -N (R 3) - (C 1 -C 6) - alkyl, heteroaryl, -N (R 3) - (C 1 -C 6) - alkyl, a heterocyclic group -N (R 3) -(C 1 -C 6 )-alkyl, phenyl-S(O) n -(C 1 -C 6 )-alkyl, heteroaryl-S(O) n -(C 1 -C 6 )- An alkyl group, a heterocyclic group-S(O) n -(C 1 -C 6 )-alkyl group, wherein the last 15 groups are respectively substituted by s groups selected from the group consisting of the following groups; : nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, (R 3 2 N(O) 2 S and R 3 O-(C 1 -C 6 )-alkyl, and wherein the heterocyclic group carries n pendant oxy groups, R 3 is hydrogen, (C 1 -C 6 )-alkane , halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, ( C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or phenyl, R 4 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkane , (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or phenyl, R 5 is hydrogen or (C 1 -C 4 )-alkyl, and R 6 is (C 1 -C 4 Or a phenyl group, which is substituted by m groups selected from the group consisting of halogen, nitro, cyano, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-haloalkoxy, R 7 is hydrogen, (C 1 -C 4 )-alkyl or (C 1 -C 4 )-alkoxy, R 8 is hydrogen or (C 1 -C 4 )-alkyl, or R 7 and R 8 together with the nitrogen atom to which they are attached form a 5- or 6-member saturation a partially saturated or unsaturated ring additionally comprising n heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, and substituted by m groups selected from the group consisting of halogens and cyanogens a group, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy and (C 1 -C 4 )-haloalkoxy, R 9 is halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 4 )-halane Oxy or (C 1 -C 4 )-alkoxy-(C 1 -C 4 )-alkyl, m is 0, 1, 2, 3, 4 or 5, n is 0, 1 or 2, s is 0, 1, 2 or 3, t is 0 or 1. 根據請求項第1項之亞磺醯亞胺基-或磺醯亞胺基苯甲醯基衍生物,其中 Q 為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基,Rb、Rc、Rf及Rg 分別獨立為氫或(C1-C4)-烷基,Rd、Re 分別獨立為氫或(C1-C4)-烷基或與其所附接之碳原子共同形成羰基,Rh 為氫,Ri 為(C1-C4)-烷基,Rk 為氫、(C1-C4)-烷基、(C3-C7)-環烷基,A及Y 分別獨立為氧或(C1-C4)-伸烷基,其係經n個R9基團取代,X 為硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷 基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基且其中雜環基帶有n個側氧基,Z 為氫、硝基、鹵素、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C2-C6)-烯基、(C2-C6)-炔基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、(R5O)2(O)P、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、NC-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R1(O)C(R1)N-(C1-C6)-烷基、R2(O)2S(R1)N-(C1-C6)-烷基、R2O(O)C(R1)N-(C1-C6)-烷基、(R1)2N(O)C(R1)N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基、R1O(O)2S-(C1-C6)-烷基、(R1)2N(O)2S-(C1-C6)-烷基、(R5O)2(O)P-(C1-C6)-烷基、苯基、雜芳基、雜環基、苯基-(C1-C6)-烷基、雜芳基-(C1-C6)-烷基、雜環基-(C1-C6)-烷基,其中最後述及之6個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、氰基、硫氰醯基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R1O、(R1)2N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S及R1O-(C1-C6)-烷基且其中雜環基帶有n個側氧基,W 為氫、鹵素、硝基、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C7)-環烷基、(C1-C6)-烷氧基、(C1-C6)-烷基-(O)nS-、R1O(O)C、(R1)2N、R1(O)C(R1)N或R2(O)2S(R1)N,R 為(C1-C6)-烷基,其係分別經s個選自下列各物所組成群中之 基團取代:鹵素、氰基、(C3-C6)-環烷基、R1(O)C、R1(R1ON=)C、R1O(O)C、(R1)2N(O)C、R2(O)2S(R1)N(O)C、R1O、(R1)2N、R1(O)C(R1)N、R2(O)2S(R1)N、R2O(O)C(R1)N、(R1)2N(O)C(R1)N、R2(O)nS、R1O(O)2S、(R1)2N(O)2S、R1(O)C(R1)N(O)2S、R2O(O)C(R1)N(O)2S及(R1)2N(O)C(R1)N(O)2S或為(C3-C6)-環烷基,其係分別經s個選自下列各物所組成群中之基團取代:鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、R1O(O)C及(R1)2N(O)C,R’ 為氫、硝基、氰基、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、鹵-(C3-C6)-環烷基-(C1-C6)-烷基、R1(O)C、R2O(O)C、(R1)2N(O)C、R2(O)2S、R1(O)C-(C1-C6)-烷基、R1O(O)C-(C1-C6)-烷基、(R1)2N(O)C-(C1-C6)-烷基、R1O-(C1-C6)-烷基、(R1)2N-(C1-C6)-烷基、R2(O)nS-(C1-C6)-烷基,R1 為氫、(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基,其中最後述及之9個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R2 為(C1-C6)-烷基、鹵-(C1-C6)-烷基、(C3-C6)-環烷基、鹵-(C3-C6)-環烷基、(C3-C6)-環烷基-(C1-C6)-烷基、(C1-C6)-烷基-O-(C1-C6)-烷基、環烷基-(C1-C6)-烷基-O-(C1-C6)-烷基、苯基、苯基-(C1-C6)-烷 基、雜芳基、雜芳基-(C1-C6)-烷基、雜環基、雜環基-(C1-C6)-烷基、苯基-O-(C1-C6)-烷基、雜芳基-O-(C1-C6)-烷基、雜環基-O-(C1-C6)-烷基,其中最後述及之9個基團分別經s個選自下列各物所組成群中之基團取代:硝基、鹵素、(C1-C6)-烷基、鹵-(C1-C6)-烷基、R3O(O)C、(R3)2N(O)C、R3O、(R3)2N、R4(O)nS及R3O-(C1-C6)-烷基,且其中雜環基帶有n個側氧基,R3 為氫或(C1-C6)-烷基,R4 為(C1-C6)-烷基’R5 為氫或(C1-C4)-烷基,R9 為鹵素、(C1-C4)-烷基、(C1-C4)-鹵烷基、(C1-C4)-烷氧基、(C1-C4)-鹵烷氧基或(C1-C4)-烷氧基-(C1-C4)-烷基,n 為0、1或2,s 為0、1、2或3,t 為0或1。 The sulfoximine- or sulfonimidobenzamide derivative according to Item 1 of the claim, wherein Q is a group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, and R b , R c , R f and R g are each independently hydrogen or (C 1 -C 4 )-alkyl, and R d and R e are each independently hydrogen or (C 1 -C 4 )- An alkyl group or a carbon atom to which it is attached forms a carbonyl group, Rh is hydrogen, R i is (C 1 -C 4 )-alkyl, R k is hydrogen, (C 1 -C 4 )-alkyl, C 3 -C 7 )-cycloalkyl, A and Y are each independently oxygen or (C 1 -C 4 )-alkylene, which is substituted by n R 9 groups, X is nitro, halogen, cyanide , (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3- C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-( C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 2 N(O)C, R 1 O, (R 1 ) 2 N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O) C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, (R 5 O) 2 (O) P, R 1 (O) C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N- (C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N -(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl , (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, phenyl, hetero Aryl, heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )-alkyl , wherein the last six groups are substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkane , halo-(C 1 -C 6 )-alkyl, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N ( O) 2 S and R 1 O-(C 1 -C 6 )-alkyl and wherein the heterocyclic group bears n pendant oxy groups, Z is hydrogen, nitro, halogen, cyano, (C 1 -C 6 ) -alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl , halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N(O C, R 1 O, (R 1 ) 2 N, R 1 (O) C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O(O)C(R 1 ) N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S, (R 5 O) 2 (O)P, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O(O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, NC-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )-alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N-(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R 1 )N-( C 1 -C 6 )-alkyl, R 2 O(O)C(R 1 )N-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C(R 1 )N- (C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 O(O) 2 S-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S-(C 1 -C 6 )-alkyl, (R 5 O) 2 (O)P-(C 1 -C 6 )-alkyl, phenyl, heteroaryl , heterocyclic, phenyl-(C 1 -C 6 )-alkyl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl-(C 1 -C 6 )-alkyl, The six groups mentioned in the last are substituted by s groups selected from the group consisting of nitro, halogen, cyano, thiocyanate, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, R 1 O, (R 1 ) 2 N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N(O) 2 S and R 1 O-(C 1 -C 6 )-alkyl and wherein the heterocyclic group carries n pendant oxy groups, W is hydrogen, halogen, nitro, cyanide a group, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 7 )-cycloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-alkyl-(O) n S-, R 1 O(O)C, (R 1 ) 2 N, R 1 (O)C(R 1 )N or R 2 (O) 2 S(R 1 )N, R is (C 1 -C 6 )-alkyl, which is substituted by s groups selected from the group consisting of halogen, cyano, (C 3 - C 6 )-cycloalkyl, R 1 (O)C, R 1 (R 1 ON=)C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 2 (O) 2 S(R 1 )N(O)C, R 1 O, (R 1 ) 2 N, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, R 2 O (O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) n S, R 1 O(O) 2 S, (R 1 ) 2 N ( O) 2 S, R 1 (O)C(R 1 )N(O) 2 S, R 2 O(O)C(R 1 )N(O) 2 S and (R 1 ) 2 N(O)C (R 1 )N(O) 2 S or (C 3 -C 6 )-cycloalkyl, which are each substituted with s groups selected from the group consisting of halogens, (C 1 - C 6 )-alkyl, halogen-(C 1 -C 6 -alkyl, (C 3 -C 6 )-cycloalkyl, R 1 O(O)C and (R 1 ) 2 N(O)C, R' is hydrogen, nitro, cyano, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O) C, R 2 O(O)C, (R 1 ) 2 N(O)C, R 2 (O) 2 S, R 1 (O)C-(C 1 -C 6 )-alkyl, R 1 O (O)C-(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C-(C 1 -C 6 )-alkyl, R 1 O-(C 1 -C 6 )- Alkyl, (R 1 ) 2 N-(C 1 -C 6 )-alkyl, R 2 (O) n S-(C 1 -C 6 )-alkyl, R 1 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 - C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclic, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6) - alkyl, heterocyclyl -O- (C 1 -C 6) - alkyl, wherein After the nine radicals mentioned are composed of s-th group was selected from each of the substituted groups: nitro, halogen, (C 1 -C 6) - alkyl, halo - (C 1 -C 6) -alkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S and R 3 O-(C 1 - C 6 )-alkyl, and wherein the heterocyclic group bears n pendant oxy groups, R 2 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 - C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkyl-O-(C 1 -C 6 )-alkyl, phenyl, Phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl, heterocyclyl-(C 1 -C 6 )-alkane , phenyl-O-(C 1 -C 6 )-alkyl, heteroaryl-O-(C 1 -C 6 )-alkyl, heterocyclyl-O-(C 1 -C 6 )-alkane a group in which the last 9 groups are respectively substituted by s groups selected from the group consisting of nitro, halogen, (C 1 -C 6 )-alkyl, halogen-(C 1 -C 6 )-alkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S and R 3 O- (C 1 -C 6) - alkyl, and which N-heterocyclic group having oxo, R 3 is hydrogen or (C 1 -C 6) - alkyl, R 4 is (C 1 -C 6) - alkyl 'R 5 is hydrogen or (C 1 -C 4 )-alkyl, R 9 is halogen, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, (C 1 -C 4 )-alkoxy, (C 1 - C 4 )-haloalkoxy or (C 1 -C 4 )-alkoxy-(C 1 -C 4 )-alkyl, n is 0, 1 or 2, and s is 0, 1, 2 or 3, t is 0 or 1. 根據請求項第1項之亞磺醯亞胺基-或磺醯亞胺基苯甲醯基衍生物,其中Q 為基團Q1、Q2、Q3、Q4或Q5, Ra 為羥基,Rb、Rc、Rf及Rg 分別獨立為氫或甲基,Rd、Re 為氫或與其所附接之碳原子共同形成羰基, Rh 為氫,Ri 為甲基或乙基,Rk 為氫、甲基或環丙基,A及Y 分別獨立為CH2或CH2CH2,X 為硝基、鹵素、甲基、乙基、正丙基、異丙基、三氟甲基、二氟甲基、氯二氟甲基、二氯氟甲基、三氯甲基、五氟乙基、七氟異丙基、環丙基、甲氧基、乙氧基、甲基硫烷基、甲基亞磺醯基、甲基磺醯基、甲氧基甲基、乙氧基甲基、甲氧基乙基、甲氧基乙氧基甲基、甲基硫甲基、甲基亞磺醯基甲基或甲基磺醯基甲基,Z 為氫、硝基、氰基、鹵素、甲基、乙基、正丙基、異丙基、三氟甲基、二氟甲基、氯二氟甲基、二氯氟甲基、三氯甲基、五氟乙基、七氟異丙基、環丙基、甲氧基、乙氧基、甲基硫烷基、甲基亞磺醯基或甲基磺醯基,W 為氫、氯或甲基,R 為甲基、乙基或正丙基,R’ 為氫或氰基,t 為0或1。 The sulfoximine- or sulfonimidobenzamide derivative according to Item 1 of the claim, wherein Q is a group Q1, Q2, Q3, Q4 or Q5, R a is a hydroxyl group, R b , R c , R f and R g are each independently hydrogen or a methyl group, R d , R e are hydrogen or a carbon atom attached thereto to form a carbonyl group, R h is hydrogen, R i Is methyl or ethyl, R k is hydrogen, methyl or cyclopropyl, A and Y are each independently CH 2 or CH 2 CH 2 , X is nitro, halogen, methyl, ethyl, n-propyl, Isopropyl, trifluoromethyl, difluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, pentafluoroethyl, heptafluoroisopropyl, cyclopropyl, methoxy, Ethoxy, methylsulfanyl, methylsulfinyl, methylsulfonyl, methoxymethyl, ethoxymethyl, methoxyethyl, methoxyethoxymethyl, Methyl thiomethyl, methylsulfinylmethyl or methylsulfonylmethyl, Z is hydrogen, nitro, cyano, halogen, methyl, ethyl, n-propyl, isopropyl, tri Fluoromethyl, difluoromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trichloromethyl, pentafluoroethyl, heptafluoroisopropyl, cyclopropyl, methoxy, ethoxy, A Alkylthioalkyl, methylsulfinyl or methylsulfonyl, W is hydrogen, chlorine or methyl, R is methyl, B Or n-propyl, R 'is hydrogen or cyano group, t is 0 or 1. 一種除草組成物,其包含除草活性量之至少一種根據請求項第1項之式(I)化合物。 A herbicidal composition comprising at least one compound of the formula (I) according to claim 1 of the herbicidal activity. 根據請求項第4項之除草組成物,其係與調配輔劑形成混合物。 The herbicidal composition according to item 4 of the claim, which forms a mixture with the formulated adjuvant. 根據請求項第4項之除草組成物,其包含至少另一種選自下列各物所組成群中之農藥活性化合物:殺昆蟲劑、殺蜱蟎劑、除草劑、殺真菌劑、安全劑及生長調節劑。 A herbicidal composition according to claim 4, which comprises at least one other pesticidally active compound selected from the group consisting of insecticides, acaricides, herbicides, fungicides, safeners and growth agents. Conditioner. 根據請求項第6項之除草組成物,其包含安全劑。 The herbicidal composition according to item 6 of the claim contains a safener. 根據請求項第7項之除草組成物,其包含環丙磺醯胺(cyprosulfamide)、毒喹(cloquintocet-mexyl)、吡唑解草酯(mefenpyr-diethyl)或雙苯唑酸(isoxadifen-ethyl)。 The herbicidal composition according to item 7 of the claim, which comprises cyprosulfamide, cloquintocet-mexyl, mefenpyr-diethyl or diphenyl Isoxadifen-ethyl. 根據請求項第6項之除草組成物,其另外包含其他除草劑。 The herbicidal composition according to item 6 of the claim further comprises other herbicides. 一種控制非所欲之植物之方法,其包括施用有效量之至少一種根據請求項第1項之式(I)化合物或根據請求項第4項之除草組成物至植物或有非所欲之植物生長之地區。 A method of controlling an undesired plant, comprising administering an effective amount of at least one compound according to formula (I) according to claim 1 or a herbicidal composition according to claim 4 to a plant or an unwanted plant Growing area. 一種以根據請求項第1項之式(I)化合物或根據請求項第4項之除草組成物於控制非所欲之植物上之用途。 A use of a compound according to formula (I) of claim 1 or a herbicidal composition according to claim 4 for controlling undesired plants. 根據請求項第11項之用途,其中使用式(I)化合物控制有用作物中非所欲之植物。 The use of a compound of formula (I) for controlling an undesired plant in a useful crop, according to the use of claim 11. 根據請求項第12項之用途,其中該有用植物為轉殖基因之有用植物。 According to the use of item 12 of the claim, wherein the useful plant is a useful plant for the transfer gene. 一種式(II)化合物, 其中Q*為羥基、乙氧基、甲氧基或氯,及R、R'、X、W、Z與t係如請求項第1項之定義。 a compound of formula (II), Wherein Q* is hydroxy, ethoxy, methoxy or chloro, and R, R', X, W, Z and t are as defined in claim 1 of the claim. 一種根據請求項第14項之式(II)化合物於製備根據請求項第1項之式(I)化合物上之用途。 Use of a compound of formula (II) according to item 14 of the claim for the preparation of a compound of formula (I) according to item 1 of the claim.
TW102105508A 2012-02-21 2013-02-18 Herbicidally active sulfinimidoyl-and sulfonimidoylbenzoyl derivatives TW201339131A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12015631 2012-02-21

Publications (1)

Publication Number Publication Date
TW201339131A true TW201339131A (en) 2013-10-01

Family

ID=49770744

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102105508A TW201339131A (en) 2012-02-21 2013-02-18 Herbicidally active sulfinimidoyl-and sulfonimidoylbenzoyl derivatives

Country Status (1)

Country Link
TW (1) TW201339131A (en)

Similar Documents

Publication Publication Date Title
KR101872239B1 (en) N-(1,3,4-Oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides
CN110603250B (en) Herbicidal 4-difluoromethylbenzamides
CN104822674B (en) 1,2,4-triazine-3,5-dione-6-carboxamides and use thereof as herbicide
US9512113B2 (en) N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides
CN108290846A (en) Acylated N- (1,2,5- oxadiazole -3- bases) -, N- (1,3,4- oxadiazole -2- bases) -, N- (tetrazolium -5- bases)-and N- (triazole -5- bases)-aryl carboxylic acid amides and its purposes as herbicide
CN104854104B (en) N-(oxazol-2-yl)-aryl-carboxylic acid amides and their use as herbicides
CN106470979B (en) Herbicidally active aryl carboxylic acid amides
CN107922395B (en) Herbicidal N- (tetrazol-5-yl) -and N- (triazol-5-yl) arylcarboxamide derivatives
CN107709317A (en) N (base of 1,3,4 oxadiazole 2) aryl carboxamides derivative with herbicide effect
US9370184B2 (en) 6-pyridone-2-carbamoyl-azoles and their use as herbicides
JP2016537419A (en) Pyridazinone derivatives and their use as herbicides
US9914710B2 (en) Bicyclic arylcarboxylic acid amides and their use as herbicides
CN106660951A (en) Herbicidally active n-(1-methyltetrazol-5-yl)benzoic acid amides
US20160326135A1 (en) 2-hetaryl-pyridazinone derivatives and their use as herbicides
JP6084988B2 (en) Herbicide sulfinimidoyl- and sulfonimidylbenzoyl derivatives
US9409881B2 (en) Herbicidally active 6′-phenyl-2,2′-bipyridine-3-carboxylic acid derivatives
TW201339131A (en) Herbicidally active sulfinimidoyl-and sulfonimidoylbenzoyl derivatives
TW201348217A (en) Herbicidally active sulfin-and sulfonimidoylbenzamides
JP2015525789A (en) Herbicidal activity 2'-phenyl-2,4'-bipyridine-3-carboxylic acid derivative
CN106458927A (en) 2-(hetero)aryl-pyridazinones and their use as herbicides